<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Cyclodestructive procedures for refractory glaucoma - Chen, MF - 2019 | Cochrane Library</title> <meta content="Cyclodestructive procedures for refractory glaucoma - Chen, MF - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012223.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Cyclodestructive procedures for refractory glaucoma - Chen, MF - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012223.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012223.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Cyclodestructive procedures for refractory glaucoma" name="citation_title"/> <meta content="Monica F Chen" name="citation_author"/> <meta content="Stein Eye Institute, UCLA" name="citation_author_institution"/> <meta content="Carole H Kim" name="citation_author"/> <meta content="Stein Eye Institute, UCLA" name="citation_author_institution"/> <meta content="Anne L Coleman" name="citation_author"/> <meta content="Stein Eye Institute, UCLA" name="citation_author_institution"/> <meta content="coleman@jsei.ucla.edu" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD012223.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/03/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012223.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012223.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012223.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Glaucoma Drainage Implants [adverse effects]; Aqueous Humor; Ciliary Body [*surgery]; Endoscopy; Glaucoma [*surgery]; Intraocular Pressure; Laser Coagulation [adverse effects, *methods]; Lasers, Solid‐State [therapeutic use]; Randomized Controlled Trials as Topic; Visual Acuity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012223.pub2&amp;doi=10.1002/14651858.CD012223.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Qh5938oe";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012223\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012223\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012223.pub2",title:"Cyclodestructive procedures for refractory glaucoma",firstPublishedDate:"Mar 10, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Qh5938oe&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012223.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012223.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012223.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012223.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012223.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012223.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012223.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012223.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012223.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012223.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4367 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012223.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0126"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0037"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0038"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-sec-0120"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/appendices#CD012223-sec-0131"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/table_n/CD012223StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/table_n/CD012223StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Cyclodestructive procedures for refractory glaucoma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information#CD012223-cr-0002">Monica F Chen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information#CD012223-cr-0003">Carole H Kim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information#CD012223-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Anne L Coleman</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information/en#CD012223-sec-0140">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 March 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012223.pub2">https://doi.org/10.1002/14651858.CD012223.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012223-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012223-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012223-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012223-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012223-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012223-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012223-abs-0001" lang="en"> <section id="CD012223-sec-0001"> <h3 class="title" id="CD012223-sec-0001">Background</h3> <p>Cyclodestructive procedures are often used in patients with refractory glaucoma who have failed to achieve lower intraocular pressure (IOP) from filtration procedures and maximal medical therapy. Destruction of the ciliary body helps to lower IOP by reducing aqueous humor formation. Of the many types of cyclodestructive procedures, laser cyclophotocoagulation (CPC) has become the most common surgical method for reducing aqueous inflow. Options for CPC are wide‐ranging: they can be performed using a neodymium:yttrium‐aluminum‐garnet (Nd:YAG) or diode laser and laser energy can be delivered by either the contact or non‐contact method. Another cyclodestructive procedure is endoscopic cyclophotocoagulation (ECP), which the ophthalmologist can use selectively to target the ciliary epithelium and ablate ciliary body tissue. There is debate regarding which cyclodestructive method is best and how they compare to other glaucoma surgeries. </p> </section> <section id="CD012223-sec-0002"> <h3 class="title" id="CD012223-sec-0002">Objectives</h3> <p>To assess the relative effectiveness and safety of cyclodestructive procedures compared with other procedures in people with refractory glaucoma of any type and to assess the relative effectiveness and safety of individual cyclodestructive procedures compared with each other. </p> </section> <section id="CD012223-sec-0003"> <h3 class="title" id="CD012223-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2018, Issue 9); Ovid MEDLINE; Embase.com; PubMed; LILACS BIREME; ClinicalTrials.gov and the WHO ICTRP. The date of the search was 21 September 2018. </p> </section> <section id="CD012223-sec-0004"> <h3 class="title" id="CD012223-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials or quasi‐randomized trials in which participants underwent a secondary procedure for refractory glaucoma. We included trials with any laser type, route of administration, and laser settings. The primary comparison was any cyclodestructive procedure versus another glaucoma treatment, and the secondary comparisons were individual cyclodestructive procedures versus another cyclodestructive procedure. </p> </section> <section id="CD012223-sec-0005"> <h3 class="title" id="CD012223-sec-0005">Data collection and analysis</h3> <p>Two review authors independently reviewed the titles and abstracts from the database searches, and after retrieving the full‐text reports of those that were potentially relevant, classified the full‐text articles as included or excluded. Two review authors independently extracted data from the included studies and assessed the risk of bias. Discrepancies were resolved by discussion or by consultation with a third review author when necessary. </p> </section> <section id="CD012223-sec-0006"> <h3 class="title" id="CD012223-sec-0006">Main results</h3> <p>We included five trials reporting data for 330 eyes (326 participants). One study to had a low risk of bias for most domains and the other studies had an overall unclear risk of bias. This review includes four different comparisons: 1) ECP versus Ahmed implant, 2) micropulse CPC versus continuous‐wave CPC; 3) CPC with a diode versus Nd:YAG laser; and 4) CPC with an Nd:YAG laser emitting 8J versus 4J. </p> <p>No study reported data for our primary outcome, change from baseline in pain severity as reported by the participant or change in number of pain medications. </p> <p>For our primary comparison, we included one trial that compared ECP with the Ahmed implant. At 12‐month follow‐up, the mean difference (MD) in IOPs between groups was ‐1.14 mmHg (95% confidence interval (CI) ‐4.21 to 1.93; 58 participants; low‐certainty evidence (LCE)). At 24 months postintervention, we found very LCE suggesting that visual acuity may be better among participants in the ECP group than in the Ahmed implant group (MD ‐0.24 logMAR, 95% CI ‐0.52 to 0.04; 54 participants), and the difference in the mean number of glaucoma medications used by participants in each group was unclear (MD ‐0.50, 95% CI ‐1.17 to 0.17; 54 participants; very LCE). Reported adverse events in the ECP group (34 participants) were one case each of hypotony, phthisis bulbi, retinal detachment, and choroidal detachment; in the Ahmed implant group (34 participants) there was one case of endophthalmitis, two cases of retinal detachment, and six cases of choroidal detachment. </p> <p>Three types of comparisons from four included studies provided data for our secondary comparisons. In the study that compared micropulse with continuous‐wave CPC, median IOP was reported to be similar between the two groups at all time points. At 18 months postintervention, the median number of IOP‐lowering medications was reduced from two to one in both groups. One participant in the micropulse and two in the continuous group exhibited worsened visual acuity. One case of prolonged inflammation was seen in the micropulse group (23 participants). Seven cases of prolonged inflammation, five cases of hypotony, and one case of phthisis bulbi were seen in the continuous group (23 participants). </p> <p>Two studies compared CPC using a semiconductor diode versus an Nd:YAG laser. At 12 months postintervention, the MD in IOP was 1.02 mmHg (95% CI ‐1.49 to 3.53) in one study (LCE). The second study did not report mean IOP beyond three months of follow‐up. Neither study reported the mean change in best‐corrected visual acuity or number of glaucoma medications. Both studies reported hypotony as an adverse event in three participants in each study. </p> <p>One study compared different energy settings of the same Nd:YAG laser. At 12‐month follow‐up, visual acuity was unchanged or improved in 21 of 33 participants in the 8J group and 20 of 27 participants in the 4J group (risk ratio 0.86, 95% CI 0.61 to 1.21; very LCE). More participants in the 8J group reduced the number of medications taken compared with the 4J group (RR 1.49, 95% CI 0.76 to 2.91; 50 participants; very low‐certainty evidence). The presence of fibrin or hyphema were seen in five participants who received 8J and none who received 4J. There was a severe anterior chamber reaction in 11 of 26 (42%) participants who received 8J of energy and 2 of 21 (10%) participants who received 4J of energy. </p> </section> <section id="CD012223-sec-0007"> <h3 class="title" id="CD012223-sec-0007">Authors' conclusions</h3> <p>Evidence from five studies included in this review was inconclusive as to whether cyclodestructive procedures for refractory glaucoma result in better outcomes and fewer complications than other glaucoma treatments, and whether one type of cyclodestructive procedure is better than another. The most commonly reported adverse events across all five studies were hypotony and phthisis bulbi. Large, well‐designed randomized controlled trials are needed. Patient‐reported outcomes such as pain and quality of life should be considered as primary outcomes or important secondary outcomes of future trials. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012223-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012223-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012223-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012223-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012223-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012223-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012223-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012223-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012223-abs-0005" lang="en"> <h3>Laser surgery that lowers eye pressure by destroying a part of the eye that produces fluid inside the eye for people with uncontrolled glaucoma </h3> <p><b>What is the aim of this review?</b><br/> The aim of this Cochrane Review was to find out how laser procedures compare to other approaches for lowering the pressure in the eye for people with glaucoma that has not responded to other types of treatment. We collected and analyzed all relevant studies of cyclodestructive procedures to answer this question and found five studies. </p> <p><b>Key messages</b><br/> There was not enough information to compare the different surgery options to each other. We were unable to conclude which type of surgery worked the best and was the safest. </p> <p><b>What was studied in this review?</b><br/> Some people who have glaucoma (damage to the optic nerve in the back of the eye) also have a buildup of pressure within the eye. This pressure may be because the eye has difficulty draining the fluid. If the ciliary body is destroyed, it can no longer produce too much fluid. Doing this may reduce the pressure within the eye and provide pain relief to people with glaucoma. There are several ways to destroy the ciliary body, which is known as cyclodestruction. Doctors can use a laser to destroy cells in the ciliary body, or they can freeze the cells. We wanted to compare these types of surgeries with more traditional surgeries for glaucoma. The laser surgery can be done in many different ways because there are different types of lasers and methods for using them. We also aimed to compare these laser surgeries with each other to see whether any method worked better than others. </p> <p><b>What are the main results of this review?</b><br/> We found five studies that examined procedures to destroy the ciliary body. One compared using a laser to destroy the cells to another type of surgery that involved implanting a tube in the eye to carry away extra fluid. Four of the studies compared different types of lasers or different methods of applying the laser to the eye. We wanted to find out whether these surgeries helped reduce pain in people with glaucoma, but only two of the five studies asked participants about pain. </p> <p>Two of the studies compared the same two types of lasers; we combined their data to help us understand the overall results. The two studies reported on the level of pressure in the eye after the surgeries. We found that both types of laser surgeries caused about the same amount of drop in pressure. We had only low confidence in these results because one of the studies had many participants lost to follow‐up and did not report what had happened to them. </p> <p>We were interested in learning how participants felt after the surgery, however none of the included studies asked participants this question. Future studies should ask this important question of participants. We also believe that future studies should ask participants about whether their pain was less after having the surgery. </p> <p><b>How up‐to‐date is the review?</b><br/> We searched for studies published up to 21 September 2018. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012223-sec-0126" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012223-sec-0126"></div> <h3 class="title" id="CD012223-sec-0127">Implications for practice</h3> <section id="CD012223-sec-0127"> <p>Due to differences in interventions, the evidence from the five studies included in this review was inconclusive, and we cannot make any clinical recommendations regarding the use of cyclodestructive procedures. We were unable to answer our main questions as to whether cyclodestructive procedures for refractory glaucoma result in better outcomes or fewer complications than other glaucoma treatments and if so, if one type of cyclodestructive procedure is better than the others. Several of our comparisons had only one included study, and a new trial of the same comparison would be very likely to change the estimate. For the comparison that had two included studies, cyclophotocoagulation with a neodymium:yttrium‐aluminum‐garnet (Nd:YAG) laser compared to cyclophotocoagulation with a diode laser, we rated the certainty of the evidence as low for the treatments' effects on intraocular pressure, the only outcome we were able to synthesize. Our primary outcome of changes in pain was either not addressed at all or not addressed adequately for comparison in the included studies. </p> </section> <h3 class="title" id="CD012223-sec-0128">Implications for research</h3> <section id="CD012223-sec-0128"> <p>Large, well‐designed randomized controlled trials comparing different types of cyclodestructive procedures with other glaucoma surgeries are needed. If cyclophotocoagulation is found to be the most effective and/or safest cyclodestructive procedure, other studies addressing the various parameters (Nd:YAG versus diode laser, contact versus non‐contact, amount of energy, and micropulse versus continuous wave) are warranted. The types of participants should be addressed with care, as there may be differences in effectiveness among participants who have had previous surgical intervention and those who have not. Despite the fact that people with refractory glaucoma often have advanced disease, patient‐reported outcomes such as pain and quality of life are needed and should be included in the primary outcomes of these trials. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012223-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012223-sec-0029"></div> <div class="table" id="CD012223-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endoscopic cyclophotocoagulation compared with the Ahmed drainage implant for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Endoscopic cyclophotocoagulation compared with the Ahmed drainage implant for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> endoscopic cyclophotocoagulation (ECP) </p> <p><b>Comparison:</b> Ahmed drainage implant </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>ECP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Ahmed implant</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study reported IOP at 12 months postintervention rather than the mean change in IOP from baseline. At 12 months postintervention, the MD was ‐1.14 mmHg (95% CI ‐4.21 to 1.93) when comparing ECP with the Ahmed implant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean change in visual acuity at 12 months postintervention was not reported. At 24 months postintervention, visual acuity was better among participants in the ECP group than in the Ahmed implant group (MD ‐0.24 logMAR, 95% CI ‐0.52 to 0.04). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in mean deviation in study eyes</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean number of glaucoma medications used by participants in each group was reported at 24 months rather than at 12 months (MD ‐0.50, 95% CI ‐1.17 to 0.17). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events were reported up to 24 months postintervention. In the ECP group (34 participants), there was 1 case each of hypotony, phthisis bulbi, retinal detachment, and choroidal detachment. In the Ahmed implant group (34 participants), there was 1 case of endophthalmitis, 2 cases of retinal detachment, and 6 cases of choroidal detachment. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to high risks of bias (selection bias, performance bias, and attrition bias).<br/> <sup>2</sup>Downgraded due to imprecision (wide confidence intervals).<br/> <sup>3</sup>Downgraded due to indirectness (outcome assessed at a different time point). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012223-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Micropulse versus continuous‐wave cyclophotocoagulation for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Micropulse versus continuous‐wave cyclophotocoagulation for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> micropulse cyclophotocoagulation (CPC) </p> <p><b>Comparison:</b> continuous‐wave CPC </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Micropulse CPC</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Continuous‐wave CPC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain control at 12 months was not assessed. The study investigators asked participants to rate their pain levels as "no pain," "mild," "moderate," or "severe" before and 1 week after surgery; however, these assessments were attributed to pain related to the surgery itself rather than pain due to glaucoma. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study reported median IOP at a time point rather than mean change in IOP from baseline. Median IOP was reported to be similar between the 2 groups at all time points. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 participant in the micropulse CPC group and 2 participants in the continuous‐wave CPC group exhibited worsened visual acuity. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in the mean deviation in study eyes</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 18 months postintervention, the median number of IOP‐lowering medications was reduced from 2 to 1 in both groups. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fewer complications were observed in the micropulse CPC group than in the continuous‐wave CPC group up to 18 months postintervention. In the micropulse CPC group (23 participants), there was 1 case of prolonged inflammation. In the continuous‐wave CPC group (23 participants), there were 7 cases of prolonged inflammation, 5 cases of hypotony, and 1 case of phthisis bulbi. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>RCT:</b> randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012223-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Comparison of two cyclophotocoagulation lasers for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Cyclophotocoagulation using a semiconductor diode laser compared with cyclophotocoagulation using an Nd:YAG laser for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> semiconductor diode laser </p> <p><b>Comparison:</b> Nd:YAG laser </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Nd:YAG laser</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Semiconductor diode laser</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported mean IOP at 12 months postintervention rather than the mean change in IOP from baseline. At 12 months postintervention, the MD was 1.02 mmHg (95% CI ‐1.49 to 3.53) when comparing the semiconductor diode laser with the Nd:YAG laser. The second study did not report mean IOP beyond 3 months of follow‐up. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported that evaluations of visual acuity measurements were inconclusive due to the poor visual function of eyes at entry, and the other study reported that at the last follow‐up visit, 25 of 34 participants in the semiconductor diode group and 25 of 30 participants in the Nd:YAG group showed increased corrected visual acuity of more than 2 lines on the Snellen chart (or 1 line on the low‐vision category) or no change in corrected visual acuity (RR 0.88, 95% CI 0.68 to 1.14). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in the mean deviation in study eyes</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported adverse events at 12 months follow‐up, and the other reported only adverse events that occurred the day following surgery, so data could not be combined. Hypotony was reported in both studies and occurred in 3 participants in each study. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>Nd:YAG:</b> neodymium:yttrium‐aluminum‐garnet; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to unclear or high risks of bias (selection bias, performance bias, and attrition bias).<br/> <sup>2</sup>Downgraded due to imprecision (wide confidence intervals).<br/> <sup>3</sup>Downgraded due to indirectness (outcome assessed at a different time point). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012223-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Comparison of two cyclophotocoagulation energy levels for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Cyclophotocoagulation using an Nd:YAG at 4 J versus 8 J for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> 4 J </p> <p><b>Comparison:</b> 8 J </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 J</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 J</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported levels of pain 1 day postintervention in a subset of participants: 8/26 participants in the 8‐joule group reported no pain on the day after surgery compared with 12/24 participants in the 4‐joule group (RR 0.62, 95% CI 0.31 to 1.24). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in IOP was only measured at the 2‐hour and 1‐day postintervention examinations.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual acuity was unchanged or improved in 21/33 participants in the 8‐joule group and 20/27 participants in the 4‐joule group (RR 0.86, 95% CI 0.61 to 1.21). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in the mean deviation in study eyes</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17/31 (54.8%) participants in the 8‐joule group and 7/19 (36.8%) participants in the 4‐joule group reduced the number of medications they were taking, though the time point of this assessment was not reported (RR 1.49, 95% CI 0.76 to 2.91). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severe reactions, defined as the presence of fibrin or hyphema, were seen in 5 participants who received 8 J of energy and none who received 4 J of energy 2 hours after the intervention. 1 day after surgery, there was a severe anterior chamber reaction in 11/26 (42%) participants who received 8 J of energy and 2/21 (10%) participants who received 4 J of energy. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>Nd:YAG:</b> neodymium:yttrium‐aluminum‐garnet; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to unclear or high risks of bias (selection bias, performance bias, and attrition bias).<br/> <sup>2</sup>Downgraded due to imprecision (wide confidence intervals).<br/> <sup>3</sup>Downgraded due to indirectness (outcome assessed at a different time point). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012223-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012223-sec-0030"></div> <section id="CD012223-sec-0031"> <h3 class="title" id="CD012223-sec-0031">Description of the condition</h3> <p>Glaucoma is a chronic progressive optic neuropathy associated with structural damage to the optic nerve and associated visual field loss, which can lead to vision loss and blindness if left undiagnosed and untreated (<a href="./references#CD012223-bbs2-0050" title="FosterPJ , BuhrmannR , QuigleyHA , JohnsonGJ . The definition and classification of glaucoma in prevalence surveys. British Journal of Ophthalmology2002;86(2):238‐42. ">Foster 2002</a>). Glaucoma is a heterogeneous group of conditions with multiple etiologies. The two main types are open‐angle glaucoma (OAG) and angle‐closure glaucoma (ACG). Neovascular glaucoma is a severe form of secondary glaucoma that results from occlusion of the trabecular meshwork and secondary closure of the angle by fibrovascular tissue proliferation. </p> <p>Known risk factors that contribute to damage to the optic nerve include elevated intraocular pressure (IOP), older age, positive family history of glaucoma, African ancestry, high myopia, high cup‐to‐optic disk ratios, exfoliation syndrome, and decreased central corneal thickness (<a href="./references#CD012223-bbs2-0047" title="ColemanAL , MigliorS . Risk factors for glaucoma onset and progression. Survey of Ophthalmology2008;53(6 Suppl):S3‐10. ">Coleman 2008</a>; <a href="./references#CD012223-bbs2-0053" title="GordonMO , BeiserJA , BrandtJD , HeuerDK , HigginbothamEJ , JohnsonCA , et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open‐angle glaucoma. Archives of Ophthalmology2002;120(6):714‐20. ">Gordon 2002</a>; <a href="./references#CD012223-bbs2-0059" title="LandersJ , GoldbergI , GrahamSL . Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma. Clinical and Experimental Ophthalmology2002;30(4):242‐7. ">Landers 2002</a>; <a href="./references#CD012223-bbs2-0066" title="MedeirosFA , SamplePA , ZangwillLM , BowdC , AiharaM , WeinrebRN . Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. American Journal of Ophthalmology2003;136(5):805‐13. ">Medeiros 2003</a>; <a href="./references#CD012223-bbs2-0074" title="QuigleyHA . Glaucoma. Lancet2011;377(9774):1367‐77. ">Quigley 2011</a>). However, IOP remains the only modifiable risk factor for glaucoma and prognostic factor for glaucoma outcomes. Therapies for glaucoma, regardless of disease mechanism, thus target IOP reduction (<a href="./references#CD012223-bbs2-0048" title="ColemanAL . Advances in glaucoma treatment and management: surgery. Investigative Ophthalmology and Visual Science2012;53(5):2491‐4. ">Coleman 2012</a>). Normally, the rate of aqueous humor production by the ciliary body equals the rate of its outflow. Intraocular pressure increases when part or all of the aqueous humor drainage system is blocked (<a href="./references#CD012223-bbs2-0069" title="PanY , VarmaP . Natural history of glaucoma. Indian Journal of Ophthalmology2011;59(Suppl 1):S19‐23. ">Pan 2011</a>). Increased IOP due to resistance to outflow is the presumed mechanism of OAG, the most common type of glaucoma. </p> <p>Randomized clinical trials of participants with glaucoma have shown that there is a clear benefit to lowering IOP with medications, laser procedures, and incisional surgery to prevent further optic nerve damage and visual field deterioration (<a href="./references#CD012223-bbs2-0044" title="BurrJ , Azuara‐BlancoA , AvenellA , TuulonenA . Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD004399.pub3] ">Burr 2012</a>; <a href="./references#CD012223-bbs2-0045" title="Collaborative Normal‐Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal‐tension glaucoma. American Journal of Ophthalmology1998;126(4):498‐505. ">CNTGS 1998</a>; <a href="./references#CD012223-bbs2-0056" title="HeijlA , LeskeMC , BengtssonB , HymanL , BengtssonB , HusseinM , et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology2002;120(10):1268‐79. ">Heijl 2002</a>; <a href="./references#CD012223-bbs2-0060" title="LeskeMC , HeijlA , HusseinM , BengtssonB , HymanL , KomaroffE , et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Archives of Ophthalmology2003;121(1):48‐56. ">Leske 2003</a>; <a href="./references#CD012223-bbs2-0061" title="LichterPR , MuschDC , GillespieBW , GuireKE , JanzNK , WrenPA , et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology2001;108(11):1943‐53. ">Lichter 2001</a>; <a href="./references#CD012223-bbs2-0082" title="VanVeldhuisenPC , EdererF , GaasterlandDE , SullivanEK , BeckA , PrumBEJr , et al. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. American Journal of Ophthalmology2000;130(4):429‐40. ">VanVeldhuisen 2000</a>; <a href="./references#CD012223-bbs2-0083" title="VassC , HirnC , SynchaT , FindlO , SacuS , BauerP , et al. Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD003167.pub3] ">Vass 2007</a>). </p> <section id="CD012223-sec-0032"> <h4 class="title">Epidemiology</h4> <p>Glaucoma is an increasingly critical public health problem due to the aging world population. Glaucoma is the leading cause of irreversible blindness and the second leading cause of blindness worldwide (<a href="./references#CD012223-bbs2-0074" title="QuigleyHA . Glaucoma. Lancet2011;377(9774):1367‐77. ">Quigley 2011</a>). <a href="./references#CD012223-bbs2-0078" title="ThamYC , LiX , WongTY , QuigleyHA , AungT , ChengCY . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta‐analysis. Ophthalmology2014;121(11):2081‐90. ">Tham 2014</a> reported that the global prevalence of glaucoma for people aged 40 to 80 years is 3.54%. <a href="./references#CD012223-bbs2-0078" title="ThamYC , LiX , WongTY , QuigleyHA , AungT , ChengCY . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta‐analysis. Ophthalmology2014;121(11):2081‐90. ">Tham 2014</a> also projected that by 2040 the number of people with glaucoma worldwide will increase to 111.8 million. Open‐angle glaucoma is the most common type of glaucoma and accounts for 74% of cases worldwide (<a href="./references#CD012223-bbs2-0072" title="QuigleyHA . Number of people with glaucoma worldwide. British Journal of Ophthalmology1996;80(5):389‐93. ">Quigley 1996</a>). Worldwide, of people over 40 years old, 2% are estimated to have OAG, 0.7% to have ACG, and 0.4% to have neovascular glaucoma (<a href="./references#CD012223-bbs2-0072" title="QuigleyHA . Number of people with glaucoma worldwide. British Journal of Ophthalmology1996;80(5):389‐93. ">Quigley 1996</a>; <a href="./references#CD012223-bbs2-0073" title="QuigleyHA , BromanAT . The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology2006;90(3):262‐7. ">Quigley 2006</a>). In OAG, incidence by gender is similar; however, people of African ancestry have almost three times the age‐adjusted prevalence than white people (<a href="./references#CD012223-bbs2-0051" title="FriedmanDS , WolfsRC , O'ColmainBJ , KleinBE , TaylorHR , WestS , et al. Prevalence of open‐angle glaucoma among adults in the United States. Archives of Ophthalmology2004;122(4):532‐8. ">Friedman 2004</a>). There also are considerable differences in prevalence by ethnicity in ACG. The highest rates of ACG have been reported in Chinese, Inuit, and other Asian populations (<a href="./references#CD012223-bbs2-0055" title="HeM , FosterPJ , GeJ , HuangW , ZhengY , FriedmanDS , et al. Prevalence and clinical characteristics of glaucoma in adult Chinese: a population‐based study in Liwan District, Guangzhou. Investigative Ophthalmology and Visual Science2006;47(7):2782‐8. ">He 2006</a>; <a href="./references#CD012223-bbs2-0081" title="VanRensGH , ArkellSM , CharltonW , DoesburgW . Primary angle‐closure glaucoma among Alaskan Eskimos. Documenta Ophthalmologica1988;70(2‐3):265‐76. ">Van Rens 1988</a>). </p> </section> <section id="CD012223-sec-0033"> <h4 class="title">Symptoms and diagnosis</h4> <p>Open‐angle glaucoma is often called the 'silent thief of sight' because it can cause irreversible damage without any symptoms at all. People with glaucoma typically do not notice visual field loss until central vision is affected in a late stage of the disease; 50% to 90% of people with glaucoma are unaware that they have glaucoma (<a href="./references#CD012223-bbs2-0085" title="WeinrebRN , AungT , MedeirosFA . The pathophysiology and treatment of glaucoma: a review. JAMA2014;311(18):1901‐11. ">Weinreb 2014</a>). </p> <p>Angle‐closure glaucoma can be categorized into acute and chronic cases. Acute ACG requires immediate management to avoid blindness. People with acute ACG present with a painful red eye, blurred vision, headache, nausea, and vomiting (<a href="./references#CD012223-bbs2-0085" title="WeinrebRN , AungT , MedeirosFA . The pathophysiology and treatment of glaucoma: a review. JAMA2014;311(18):1901‐11. ">Weinreb 2014</a>). People with chronic ACG present with similar symptoms as those with OAG. Glaucoma is diagnosed using tonometry, gonioscopy, optic nerve examination and imaging, corneal pachymetry, pupil examination, and visual field assessment. </p> </section> </section> <section id="CD012223-sec-0034"> <h3 class="title" id="CD012223-sec-0034">Description of the intervention</h3> <p>Cyclodestructive procedures, first introduced by Vogt in the 1930s (<a href="./references#CD012223-bbs2-0084" title="VogtA . Attempts to decrease intraocular pressure by means of diathermy damage to the ciliary body (cyclodiathermy) [Versuche zur intraokularen druckherabsetzung mittelst diathermieschädigung des corpus ciliare (Zyklodiathermiestichelung)]. Klinische Monatsblätter für Augenheilkunde1936;97:672‐3. ">Vogt 1936</a>), are traditionally used in eyes with refractory glaucoma for whom filtration procedures have failed to lower IOP or slow disease progression; eyes with elevated IOP and limited useful vision on maximal medical therapy; and eyes with no visual potential in need of pain relief (<a href="./references#CD012223-bbs2-0039" title="AnsariE , GandhewerJ . Long‐term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non‐refractory glaucoma. Eye2007;21(7):936‐40. ">Ansari 2007</a>; <a href="./references#CD012223-bbs2-0043" title="BloomPA , TsaiJC , SharmaK , MillerMH , RiceNS , HitchingsRA , et al. “Cyclodiode”. Trans‐scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology1997;104(9):1508‐19. ">Bloom 1997</a>; <a href="./references#CD012223-bbs2-0021" title="LiuG , TangGL . Effect of transscleral diode laser cyclophotocoagulation and cyclocryosurgery in treatment of severe glaucoma. International Journal of Ophthalmology2008;8(8):1673‐4. ">Liu 2008</a>; <a href="./references#CD012223-bbs2-0070" title="PastorSA , SinghK , LeeDA , JuzychMS , LinSC , NetlandPA , et al. Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology2001;108(11):2130‐8. ">Pastor 2001</a>). The goal of treatment is to reduce aqueous humor formation through ablation or destruction of the ciliary body epithelium. A number of different modalities have been used to achieve this aim including diathermy, cryotherapy, laser, ultrasound, and surgical excision (<a href="./references#CD012223-bbs2-0040" title="BeckmanH , KinoshitaA , RotaAN , SugarHS . Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Transactions of the American Academy of Ophthalmology and Otolaryngology1972;76(2):423‐36. ">Beckman 1972</a>; <a href="./references#CD012223-bbs2-0042" title="BiettiG . Surgical intervention of the ciliary body; new trends for the relief of glaucoma. Journal of the American Medical Association1950;142(12):889‐97. ">Bietti 1950</a>; <a href="./references#CD012223-bbs2-0046" title="ColemanDJ , LizziFL , DrillerJ , RosadoAL , BurgessSE , TorpeyJH , et al. Therapeutic ultrasound in the treatment of glaucoma. II. Clinical applications. Ophthalmology1985;92(3):347‐53. ">Coleman 1985</a>; <a href="./references#CD012223-bbs2-0077" title="ShieldsMB . Cyclodestructive surgery for glaucoma: past, present, and future. Transactions of the American Ophthalmological Society1985;83:285‐303. ">Shields 1985</a>; <a href="./references#CD012223-bbs2-0084" title="VogtA . Attempts to decrease intraocular pressure by means of diathermy damage to the ciliary body (cyclodiathermy) [Versuche zur intraokularen druckherabsetzung mittelst diathermieschädigung des corpus ciliare (Zyklodiathermiestichelung)]. Klinische Monatsblätter für Augenheilkunde1936;97:672‐3. ">Vogt 1936</a>). Laser cyclophotocoagulation (CPC) and endoscopic cyclophotocoagulation (ECP) are the most commonly used procedures. Laser cyclophotocoagulation, first introduced in the 1970s by Beckman (<a href="./references#CD012223-bbs2-0041" title="BeckmanH , SugarHS . Neodymium laser cyclocoagulation. Archives of Ophthalmology1973;90(1):27–8. ">Beckman 1973</a>), has become the most common surgical method for reducing aqueous inflow. It can be performed using a neodymium:yttrium‐aluminum‐garnet (Nd:YAG) or diode laser (<a href="./references#CD012223-bbs2-0063" title="LinP , WollsteinG , GlavasIP , SchumanJS . Contact transscleral neodymium:yttrium‐aluminum‐garnet laser cyclophotocoagulation. Long‐term outcome. Ophthalmology2004;111(11):2137‐43. ">Lin 2004</a>; <a href="./references#CD012223-bbs2-0065" title="MartinKR , BroadwayDC . Cyclodiode laser therapy for painful, blind glaucomatous eyes. British Journal of Ophthalmology2001;85(4):474‐6. ">Martin 2001</a>), and laser energy can be delivered by either the contact or non‐contact method (<a href="./references#CD012223-bbs2-0062" title="LinS . Endoscopic cyclophotocoagulation. British Journal of Ophthalmology2002;86(12):1434‐8. ">Lin 2002</a>). Although CPC has been used to treat refractory glaucoma successfully, significant postoperative complications (i.e. visual loss, phthisis, loss of light perception) and discomfort have been reported by people undergoing this procedure (<a href="./references#CD012223-bbs2-0063" title="LinP , WollsteinG , GlavasIP , SchumanJS . Contact transscleral neodymium:yttrium‐aluminum‐garnet laser cyclophotocoagulation. Long‐term outcome. Ophthalmology2004;111(11):2137‐43. ">Lin 2004</a>). Endoscopic cyclophotocoagulation, a newer method that specifically targets the ciliary process under direct viewing, is also used to treat refractory glaucoma. Since ECP can be used to ablate ciliary body tissue selectively, it has a lower incidence of vision‐threatening complications (<a href="./references#CD012223-bbs2-0062" title="LinS . Endoscopic cyclophotocoagulation. British Journal of Ophthalmology2002;86(12):1434‐8. ">Lin 2002</a>). </p> <p>Other commonly used glaucoma surgeries include trabeculectomy and insertion of aqueous shunts. Trabeculectomy is typically used in eyes in which medications and laser therapy are insufficient to control disease (<a href="./references#CD012223-bbs2-0071" title="PrumBEJr , RosenbergLF , GeddeSJ , MansbergerSL , SteinJD , MoroiSE , et al. Primary Open‐Angle Glaucoma Preferred Practice Pattern Guidelines (2015). Ophthalmology2016;123(1):P41‐111. ">Prum 2016</a>). Trabeculectomy is typically a filtering surgery where a block of eye filtration tissue is removed to decrease resistance to the outflow filtration of aqueous. While trabeculectomy lowers eye pressure and is considered by many ophthalmologists to be the gold‐standard glaucoma operation, it is associated with significant postoperative complications. Complications include hyphema, shallow or flat anterior chamber, hypotony, choroidal detachment, blebitis, endophthalmitis, cataract formation, and hypotony maculopathy (<a href="./references#CD012223-bbs2-0049" title="EldalyM , BunceC , ElSheikhaO , WormaldR . Non‐penetrating filtration surgery versus trabeculectomy for open‐angle glaucoma. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD007059.pub2] ">Eldaly 2014</a>). Aqueous shunts are traditionally used to manage medically uncontrolled glaucoma when trabeculectomy has failed to control IOP or is unlikely to succeed (<a href="./references#CD012223-bbs2-0071" title="PrumBEJr , RosenbergLF , GeddeSJ , MansbergerSL , SteinJD , MoroiSE , et al. Primary Open‐Angle Glaucoma Preferred Practice Pattern Guidelines (2015). Ophthalmology2016;123(1):P41‐111. ">Prum 2016</a>). Aqueous shunts consist of a tube that diverts aqueous humor to an end plate (<a href="./references#CD012223-bbs2-0067" title="MincklerD , VedulaSS , LiT , MathewM , AyyalaR , FrancisB . Aqueous shunts for glaucoma. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD004918.pub2] ">Minckler 2006</a>). Complications include hypotony, diplopia, strabismus, proptosis, tube erosion, failure, corneal decompensation, endophthalmitis, and visual loss (<a href="./references#CD012223-bbs2-0076" title="SarkisianSRJr . Tube shunt complications and their prevention. Current Opinion in Ophthalmology2009;20(2):126‐30. ">Sarkisian 2009</a>). </p> </section> <section id="CD012223-sec-0035"> <h3 class="title" id="CD012223-sec-0035">How the intervention might work</h3> <p>When part or all of the aqueous humor drainage system is reduced or blocked, IOP increases (<a href="./references#CD012223-bbs2-0069" title="PanY , VarmaP . Natural history of glaucoma. Indian Journal of Ophthalmology2011;59(Suppl 1):S19‐23. ">Pan 2011</a>; <a href="./references#CD012223-bbs2-0080" title="TurkoskiBB . Glaucoma and glaucoma medications. Orthopaedic Nursing2012;31(1):37‐41. ">Turkoski 2012</a>). Aqueous humor is produced by the ciliary body epithelium. In cyclodestructive surgery, the laser energy that targets the ciliary body epithelium induces coagulative necrosis of these tissues and results in reduction of aqueous humor production, and thus reduced IOP (<a href="./references#CD012223-bbs2-0064" title="LiuGJ , MizukawaA , OkisakaS . Mechanism of intraocular pressure decrease after contact transscleral continuous‐wave Nd:YAG laser cyclophotocoagulation. Ophthalmic Research1994;26(2):65‐79. ">Liu 1994</a>). </p> </section> <section id="CD012223-sec-0036"> <h3 class="title" id="CD012223-sec-0036">Why it is important to do this review</h3> <p>Although cyclodestructive procedures are not new, uncertainty exists regarding which cyclodestructive method is best and how they compare to other glaucoma surgeries. Additionally, much of the literature reports only small non‐comparative case series; such study designs cannot demonstrate a benefit of one therapy over another. A systematic review, ideally incorporating meta‐analysis, would be beneficial to compile information from individual studies and to estimate the relative effects of different procedures on IOP control. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012223-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012223-sec-0037"></div> <p>To assess the relative effectiveness (i.e. reduction of pain) and safety of cyclodestructive procedures (i.e. CPC and ECP) compared with other procedures (i.e. aqueous shunts) in people with refractory glaucoma of any type and to assess the relative effectiveness and safety of individual cyclodestructive procedures compared with each other. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012223-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012223-sec-0038"></div> <section id="CD012223-sec-0039"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012223-sec-0040"> <h4 class="title">Types of studies</h4> <p>We included only randomized controlled trials (RCTs) and quasi‐RCTs (e.g., studies where the method of allocation is not considered strictly random such as by alternation, date of birth, or medical record number). </p> </section> <section id="CD012223-sec-0041"> <h4 class="title">Types of participants</h4> <p>We included RCTs in which participants underwent a secondary procedure for refractory glaucoma (medically uncontrolled glaucoma for which other surgeries have failed). We included all types of glaucoma (i.e. primary open‐angle glaucoma (OAG), angle‐closure glaucoma (ACG), and secondary glaucoma such as neovascular, pigmentary, and exfoliation glaucoma). There were no restrictions based on participant age, gender, ethnicity, or comorbidity. </p> </section> <section id="CD012223-sec-0042"> <h4 class="title">Types of interventions</h4> <p>We included all trials that compared cyclodestruction with aqueous shunts or another cyclodestructive procedure (CPC or ECP). We included trials with all types of lasers (i.e. ruby, Nd:YAG, diode), routes of administration (non‐contact, contact), and laser settings. The primary comparison of interest was any cyclodestructive procedure versus another glaucoma treatment (aqueous shunts); the secondary comparisons were individual cyclodestructive procedures versus another cyclodestructive procedure. </p> </section> <section id="CD012223-sec-0043"> <h4 class="title">Types of outcome measures</h4> <section id="CD012223-sec-0044"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD012223-list-0001"> <li> <p>Change from baseline in pain severity as reported by the participant or change in number of pain medications prescribed from baseline to 12 months postintervention. </p> </li> </ol> </p> </section> <section id="CD012223-sec-0045"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD012223-list-0002"> <li> <p>Mean change in intraocular pressure (IOP) from baseline (immediate preoperative IOP) in study eyes at one week, one month, three months, six months, 12 months, and last follow‐up after the procedure, measured using Goldmann tonometry, Tono‐Pen, or another standard device. If sufficient information was available from the included studies, we planned to examine IOP in time‐to‐event analysis. When mean change in IOP from baseline was not reported, we used the mean IOP values at a time point to estimate the between‐group treatment effects. </p> </li> <li> <p>Mean change in best‐corrected visual acuity in study eyes at 12 months postintervention, measured by logarithm of the minimum angle of resolution (logMAR) chart or equivalent. </p> </li> <li> <p>Mean change in mean deviation in study eyes from baseline at 12 months postintervention as measured by automated perimetry. </p> </li> <li> <p>Mean number of prescribed glaucoma medications, both topical and systemic, at 12 months postintervention. </p> </li> <li> <p>Proportion of study eyes requiring additional glaucoma surgery by 12 months postintervention.</p> </li> </ol> </p> <section id="CD012223-sec-0046"> <h6 class="title">Adverse outcomes</h6> <p>We documented adverse outcomes reported by the included studies (i.e. prolonged inflammation, hypotony, phthisis, fibrin exudates). Since cyclodestructive surgeries are intraocular procedures, we also documented reports of endophthalmitis, retinal detachment, and choroidal hemorrhage. </p> </section> <section id="CD012223-sec-0047"> <h6 class="title">Quality of life data</h6> <p>We planned to describe and compare quality of life outcomes by procedure if available.</p> </section> </section> </section> </section> <section id="CD012223-sec-0048"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012223-sec-0049"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist searched the following electronic databases for RCTs and controlled clinical trials. We imposed no language or publication year restrictions. </p> <p> <ul id="CD012223-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 9) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 21 September 2018) (<a href="./appendices#CD012223-sec-0132">Appendix 1</a>). </p> </li> <li> <p>MEDLINE Ovid (1946 to 21 September 2018) (<a href="./appendices#CD012223-sec-0133">Appendix 2</a>). </p> </li> <li> <p>Embase.com (1947 to 21 September 2018) (<a href="./appendices#CD012223-sec-0134">Appendix 3</a>). </p> </li> <li> <p>PubMed (1948 to 21 September 2018) (<a href="./appendices#CD012223-sec-0135">Appendix 4</a>). </p> </li> <li> <p>LILACS BIREME (Latin American and Caribbean Health Science Information Database) (1982 to 21 September 2018) (<a href="./appendices#CD012223-sec-0136">Appendix 5</a>). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 21 September 2018) (<a href="./appendices#CD012223-sec-0137">Appendix 6</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 21 September 2018) (<a href="./appendices#CD012223-sec-0138">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD012223-sec-0050"> <h4 class="title">Searching other resources</h4> <p>We searched the references of reports from included studies for additional relevant studies without restrictions regarding language or date of publication. </p> </section> </section> <section id="CD012223-sec-0051"> <h3 class="title" id="CD012223-sec-0051">Data collection and analysis</h3> <section id="CD012223-sec-0052"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently reviewed the titles and abstracts of all records identified through electronic and manual searches. Each of these review authors classified titles and abstracts as either ‘definitely relevant,’ ‘possibly relevant,’ or ‘definitely not relevant.’ We retrieved the full‐text reports of all records classified as ‘definitely relevant’ or ‘possibly relevant.’ The same two review authors reviewed the full‐text articles, classifying the reported studies as either ‘definitely include’ or ‘definitely exclude.’ Any disagreements between the two review authors were resolved by discussion at each stage of selection, or by consulting a third review author when necessary. We excluded those studies labeled as ‘definitely exclude’ and documented the reasons for exclusion in the <a href="./references#CD012223-sec-0147" title="">Characteristics of excluded studies</a> table. When information needed to include or exclude a study from the review was unclear or unavailable from the study reports, we attempted to contact the study authors to clarify eligibility. </p> </section> <section id="CD012223-sec-0053"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data from the included studies using internet‐based data abstraction forms developed in collaboration with Cochrane Eyes and Vision (CEV) in the Systematic Review Data Repository (<a href="http://srdr.ahrq.gov" target="_blank">srdr.ahrq.gov</a>). We extracted data from reports from each study relevant to the study design and methods, participant characteristics, interventions, and outcomes. Any discrepancies were resolved between the two review authors by discussion or by consulting a third review author when necessary. One review author entered data into Review Manager 5 (RevMan 5) (<a href="./references#CD012223-bbs2-0075" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), and a second review author verified the entered data. </p> </section> <section id="CD012223-sec-0054"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed each included study for risk of bias using the tools described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012223-bbs2-0058" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). We assessed the following 'Risk of bias' parameters. </p> <p> <ol id="CD012223-list-0004"> <li> <p>Sequence generation.</p> </li> <li> <p>Allocation concealment before randomization.</p> </li> <li> <p>Masking of participants, personnel, and outcome assessors.</p> </li> <li> <p>Incomplete outcome data reporting.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other potential sources of bias (e.g. funding source).</p> </li> </ol> </p> <p>We assessed each trial for each criterion and judged the trial as being at either 'high,' 'low,' or 'unclear' risk of bias (lack of information or uncertainty regarding the potential for bias). </p> </section> <section id="CD012223-sec-0055"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012223-sec-0056"> <h5 class="title">Dichotomous outcomes</h5> <p>We analyzed the need for additional glaucoma surgery using summary risk ratios (RRs) with 95% confidence intervals (CIs) when data were available. </p> </section> <section id="CD012223-sec-0057"> <h5 class="title">Continuous outcomes</h5> <p>We summarized mean reduction from baseline in IOP, mean change in logMAR visual acuity, mean deviations from visual field tests, number of glaucoma medications, and any potential scale used to quantify pain (as reported by the participants) would be accepted using summary mean differences (MDs) with 95% CIs. Whenever the included studies measured continuous outcomes using different scales, we calculated standardized mean differences (SMDs). </p> </section> </section> <section id="CD012223-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>The participant was the unit of analysis. The optimal study design included one study eye per participant. We recorded whether studies enrolled one or two study eyes per participant. For trials that had included both eyes per participant, we planned to account, when possible, for intraperson correlation of outcomes as outlined in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012223-bbs2-0057" title="HigginsJPT , DeeksJJ , AltmanDG , (editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.training.cochrane.org/handbook. ">Higgins 2011</a>). We planned to use paired analysis whenever included studies used a paired‐eye design, however none of the included studies used a paired‐eye design. </p> </section> <section id="CD012223-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors to request missing details including but not limited to study methods, effect estimates, and standard deviations. Whenever study authors did not respond within two weeks, we used the data available. </p> </section> <section id="CD012223-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed both clinical and methodological heterogeneity of included studies by examining variations in participant characteristics, inclusion/exclusion criteria, and assessments of primary and secondary outcomes. We used the I² statistic (%) to determine the proportion of variation in outcomes attributable to heterogeneity rather than chance. We deemed an I² statistic value of greater than 50% as reflecting substantial heterogeneity. In addition, we examined the overlap of effect estimates and CIs among individual studies, with poor overlap interpreted as indicating heterogeneity. </p> </section> <section id="CD012223-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use funnel plots in Review Manager 5 to examine signs of asymmetry to evaluate small‐study effects and potential for publication bias if we included 10 or more studies in a meta‐analysis (<a href="./references#CD012223-bbs2-0075" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). However, the only possible meta‐analyses included outcomes from only two studies, so we did not perform this investigation. We assessed the potential for selective outcome reporting as part of the 'Risk of bias' assessment. </p> </section> <section id="CD012223-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We planned to combine the results in a meta‐analysis using a random‐effects model, as long as we did not detect any substantial heterogeneity. However, we could combine outcome data from only two included studies in meta‐analysis, so we used a fixed‐effect model. When clinical, methodological, and statistical (I² statistic value of greater than 50%) characteristics suggested substantial heterogeneity, we presented the results in a narrative summary and did not conduct a meta‐analysis. </p> </section> <section id="CD012223-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform subgroup analyses to compare effect estimates for different administration of procedures (non‐contact versus contact) and underlying causes of glaucoma (open‐angle, angle‐closure, neovascular), but there were not enough included studies to create these subgroups. </p> </section> <section id="CD012223-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses to determine the impact of excluding studies with high risk of bias, with industry funding, or without full‐length reports, but as we could include only two studies in any meta‐analyses, sensitivity analyses were not possible. </p> <section id="CD012223-sec-0065"> <h5 class="title">'Summary of findings' table</h5> <p>We followed the GRADE classification approach and used the reporting of effect estimates, imprecision, indirectness, inconsistency, and risk of bias to grade the strength of evidence for each outcome as very low, low, moderate, or high (<a href="./references#CD012223-bbs2-0054" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 6 December 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro 2015</a>). </p> <p>We included the following outcomes in the 'Summary of findings' tables for each comparison.</p> <p> <ol id="CD012223-list-0005"> <li> <p>Change from baseline in pain severity as reported by the participant or change in number of pain medications prescribed from baseline to 12 months postintervention. </p> </li> <li> <p>Mean change in IOP from baseline (immediate preoperative IOP) in study eyes at 12 months postintervention. </p> </li> <li> <p>Mean change in logMAR best‐corrected visual acuity in study eyes at 12 months postintervention.</p> </li> <li> <p>Mean change in mean deviation in study eyes from baseline at 12 months postintervention.</p> </li> <li> <p>Mean number of prescribed glaucoma medications, both topical and systemic, at 12 months postintervention. </p> </li> <li> <p>Proportion of participants with an adverse event.</p> </li> <li> <p>Change from baseline in quality of life scores at 12 months postintervention.</p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012223-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012223-sec-0066"></div> <section id="CD012223-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD012223-sec-0068"> <h4 class="title">Results of the search</h4> <p>We performed the electronic database searches on 21 September 2018, and they are up‐to‐date as of that day. The searches identified 10,310 references including articles and trial registry records (<a href="#CD012223-fig-0001">Figure 1</a>). We removed 2575 duplicate references, and two review authors independently screened the remaining 7735 references. We obtained the full‐text reports for 42 references. We identified 5 studies published as 7 reports that met the inclusion criteria for this review. We identified 3 studies on ClinicalTrials.gov, which we tagged as awaiting classification because sufficient information to make a decision about their inclusion or exclusion is currently not available. We excluded 32 references. We have reported the reasons for exclusion in the <a href="./references#CD012223-sec-0147" title="">Characteristics of excluded studies</a> tables. </p> <div class="figure" id="CD012223-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012223-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012223-sec-0069"> <h4 class="title">Included studies</h4> <p>We included 5 studies in this review reporting outcomes for 330 eyes of 326 participants. The studies are described here in summary and in more detail in the <a href="./references#CD012223-sec-0146" title="">Characteristics of included studies</a> tables. </p> <section id="CD012223-sec-0070"> <h5 class="title">Types of participants</h5> <p>Participants in all included studies had refractory glaucoma requiring a cyclodestructive procedure. <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>, <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>, and <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> enrolled participants for whom traditional surgical approaches had failed or were not possible or inappropriate. <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> enrolled participants who had at least one previous trabeculectomy; <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> allowed participants "with or without previous surgical intervention." The studies were conducted in four countries: one in Brazil (<a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>), one in Singapore (<a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>), one in the United Kingdom (<a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>), and two in the United States (<a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>; <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a>). </p> </section> <section id="CD012223-sec-0071"> <h5 class="title">Types of interventions</h5> <p>The included studies used a variety of different types of cyclodestructive surgeries. Only one of the included studies compared a cyclodestructive procedure with another glaucoma treatment, our primary comparison of interest. The other included studies compared two types of cyclodestructive procedures, our secondary comparison of interest. Each of the included studies had two study arms. </p> <p>For our primary comparison of a cyclodestructive procedure versus another glaucoma treatment, <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> compared endoscopic cyclophotocoagulation (ECP) with insertion of the Ahmed tube, a drainage implant device. </p> <p>Among the four studies that compared two types of cyclodestructive procedure, all used cyclophotocoagulation (CPC) as the cyclodestructive procedure in both study arms. <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> compared two types of contact CPC. Some participants were randomized to micropulse mode of laser delivery, with repetitive, short pulses of energy separated by rest periods, while others were randomized to conventional continuous‐wave CPC, in which continuous high energy was delivered. <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> compared non‐contact CPC using two energy levels from the same type of laser: 4 J or 8 J of laser energy from an Nd:YAG laser, while <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> compared non‐contact CPC using the Nd:YAG with another laser, a continuous‐wave semiconductor diode, which emitted at 810 nm rather than the 1064 nm of the Nd:YAG laser. <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> also compared the Nd:YAG laser with a semiconductor laser, but a different one from the one used in <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>. <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> and <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> were the only two studies from which outcome data could be combined in meta‐analyses, as they both compared the Nd:YAG laser with a semiconductor laser. The study arms in the other two studies that randomized participants to two types of CPC were too different to justify combining their outcomes. </p> </section> <section id="CD012223-sec-0072"> <h5 class="title">Types of outcomes</h5> <section id="CD012223-sec-0073"> <h6 class="title">Primary outcome</h6> <p>No study reported on our primary outcome, change from baseline in pain severity as reported by the participant or change in number of pain medications. However, <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> asked participants to rate their pain levels as "no pain," "mild," and "severe" before and one week after laser treatment. In <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>, pain was described by participants on the day after surgery as "none," "moderate," or "severe." These pain ratings were regarded as equivalent to discomfort related to the laser treatment and not related to disease. </p> </section> <section id="CD012223-sec-0074"> <h6 class="title">Secondary outcomes</h6> <p>Four studies reported mean IOP at various postoperative time points (<a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>; <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>; <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>; <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a>). <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> reported median IOP rather than mean IOP. None of the studies reported mean change in visual acuity from baseline to 12 months postintervention. In <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>, visual acuity changes were reported only for the participants who did not require further surgery; <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> commented on mean change in visual acuity postoperatively and incidence of visual acuity worsening at 24 months; and <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported number of participants with decreased visual acuity, no change, and increased corrected visual acuity. No study reported the mean number of glaucoma medications prescribed at 12 months. <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> reported the mean number of glaucoma medications at 24 months; <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> reported the median number of medications at 18 months; and <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> reported the number of participants who were taking fewer medications than at baseline. <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> and <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> reported the proportion of participants who required additional surgeries. However, <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> did not note the time point of assessment, and neither <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> nor <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> specified whether participants required non‐cyclodestructive glaucoma surgeries. All studies reported adverse outcomes, but none of the studies reported any visual field or quality of life data. </p> </section> </section> </section> <section id="CD012223-sec-0075"> <h4 class="title">Excluded studies</h4> <p>We excluded 25 studies published in 27 reports after full‐text review. The majority were excluded because they were the wrong study design, that is they were not RCTs (n = 20, 74%) (<a href="./references#CD012223-bbs2-0007" title="Alves JúniorAD , YamaneR , MottaMM . Comparative study of diode transscleral cyclophotocoagulation associated or not with periphery retinal ablation in neovascular glaucoma [Estudo comparativo da ciclofotocoagulação transescleral pelo laser de diodo associada ou não à ablação simultânea da retina periférica no gaucoma neovascular]. Revista Brasileira de Oftalmologia2003;62(8):578‐88. ">Alves Júnior</a>; <a href="./references#CD012223-bbs2-0008" title="Benitez Del Castillo SanchezJ , Benitez del CastilloJM , Morales LopezMD , Rodriguez SuarezAH . Refractory glaucoma treatment cyclophotocoagulation vs trabeculectomy with mitomycin. Archivos de la Sociedad Espanola de Oftalmologia1996;70(3):279‐88. ">Benitez Del Castillo Sanchez 1996</a>; <a href="./references#CD012223-bbs2-0009" title="BloomPA , ClementCI , KingA , NoureddinB , SharmaK , HitchingsRA , et al. A comparison between tube surgery, ND:YAG laser and diode laser cyclophotocoagulation in the management of refractory glaucoma. BioMed Research International2013; Vol. 2013:371951. [DOI: 10.1155/2013/371951] BloomPA , NoureddinBN , SharmaK , HitchingsRA , KhawPT . A matched comparison between tube surgery, Nd:YAG and diode laser cyclophotocoagulation in the management of refractory glaucoma. American Academy of Ophthalmology1996:Abstract 174. ">Bloom 2013</a>; <a href="./references#CD012223-bbs2-0011" title="ChalamKV , LinN , TripathiR . Advanced neovascular glaucoma: pars plana modified Baerveldt implant versus Nd:YAG transscleral cyclophotocoagulation. American Academy of Ophthalmology1999:Abstract 241. ">Chalam 1999</a>; <a href="./references#CD012223-bbs2-0012" title="ChalamKV , MalkaniSM , TripathiRC , AmbatiJ . Neovascular glaucoma: pars plana Baerveldt implant vs Nd:YAG transscleral cyclophotocoagulation vs YAG endocyclophotocoagulation. American Academy of Ophthalmology2001:Abstract 168. ">Chalam 2001</a>; <a href="./references#CD012223-bbs2-0013" title="ChenJP , WangR , XuHY , ZhangP , ZhangJ . Clinical observation of two operation methods for neovascular glaucoma. International Eye Science2013;13(11):2259‐61. ">Chen 2013</a>; <a href="./references#CD012223-bbs2-0014" title="CyrlinN , TresslerCS , RosensheinJS , DubayHB . Contact diode laser cyclocoagulation: a long term comparison of shorter‐duration; higher‐power vs. longer‐duration, lower‐power treatment in uncontrolled glaucoma. Investigative Ophthalmology and Visual Science1999; Vol. 40:ARVO E‐Abstract 1431. ">Cyrlin 1999</a>; <a href="./references#CD012223-bbs2-0016" title="FankhauserF , KwasniewskaS , EnglandC , DürrV . Diode versus Nd:YAG laser for cyclodestructive procedures. Ophthalmic Surgery1993;24(8):566‐7. ">Fankhauser 1993</a>; <a href="./references#CD012223-bbs2-0017" title="Goldenberg‐CohenN , BaharI , OstashinskiM , LuskyM , WeinbergerD , GatonDD . Cyclocryotherapy versus transscleral diode laser cyclophotocoagulation for uncontrolled intraocular pressure. Ophthalmic Surgery, Lasers and Imaging2005;36(4):272‐9. ">Goldenberg‐Cohen 2005</a>; <a href="./references#CD012223-bbs2-0018" title="KaushikS , PandavSS , JainR , BansalS , GuptaA . Lower energy levels adequate for effective transcleral diode laser cyclophotocoagulation in Asian eyes with refractory glaucoma. Eye2008;22(3):398‐405. ">Kaushik 2008</a>; <a href="./references#CD012223-bbs2-0019" title="Koraszewska‐MatuszewskaB , LeszczyńskiR , Samochowiec‐DonocikE , NawrockaL . Cyclodestructive procedures in secondary glaucoma in children. Klinika Oczna2003;106(1‐2 Suppl):199‐200. ">Koraszewska‐Matuszewska 2004</a>; <a href="./references#CD012223-bbs2-0024" title="NoureddinBN , Wilson‐HoltN , LavinM , JeffreyM , HitchingsRA . Advanced uncontrolled glaucoma. Nd:YAG cyclophotocoagulation or tube surgery. Ophthalmology1992;99(3):430‐7. ">Noureddin 1992</a>; <a href="./references#CD012223-bbs2-0025" title="RadaxU , MenapaceR , RigalK , PapapanosP , AmonM . A comparison of CW Nd‐YAG contact transcleral hemicyclophotocoagulation and hemicyclocryotherapy in uncontrolled primary open angle glaucoma. Spektrum der Augenheilkunde1992;6(5):228‐31. ">Radax 1992</a>; <a href="./references#CD012223-bbs2-0026" title="ShuklaM , ThakkurN . A comparative evaluation of cyclocryotherapy, cyclodiathermy and cycloanemization in glaucoma. Indian Journal of Ophthalmology 981;29(1):13‐7. ">Shukla 1981</a>; <a href="./references#CD012223-bbs2-0027" title="SuzukiY , AraieM , YumitaA , YamamotoT . Effect of cyclocryotherapy and transscleral laser cyclophotocoagulation in refractory glaucoma. Japanese Journal of Clinical Ophthalmology1989;43(6):1021‐5. ">Suzuki 1989</a>; <a href="./references#CD012223-bbs2-0029" title="WallandMJ . Diode laser cyclophotocoagulation: dose‐standardized therapy in end‐stage glaucoma. Australian and New Zealand Journal of Ophthalmology1998;26(2):135‐9. ">Walland 1998</a>; <a href="./references#CD012223-bbs2-0030" title="WeiZ , GuohuaY , JunzhongM . Long‐term results of diode versus Nd:YAG contact transscleral laser cyclophotocoagulation for refractory glaucoma. Lasers and Light in Ophthalmology1999;9(1):29‐35. ">Wei 1999</a>; <a href="./references#CD012223-bbs2-0031" title="XuS , WangY , SuG . Evaluation of surgical effectiveness for neovascular glaucoma. Chinese Ophthalmic Research2007;25(9):707‐9. ">Xu 2007</a>; <a href="./references#CD012223-bbs2-0033" title="YuJY , KahookMY , LathropKL , NeockerRJ . The effect of probe placement and type of visoelastic material on endoscopic cyclophotocoagulation laser energy transmission. Ophthalmic Surgery, Lasers and Imaging2008;39(2):133‐6. ">Yu 2008</a>; <a href="./references#CD012223-bbs2-0034" title="ZhangB . Contrast of surgical effect of two different operations for neovascular glaucoma. International Journal of Ophthalmology2010;10(4):671‐3. ">Zhang 2010</a>). We excluded five studies because participants did not meet our criteria for refractory glaucoma (medically uncontrolled glaucoma for which other surgeries have failed) (n = 7, 26%) (<a href="./references#CD012223-bbs2-0006" title="AgarwalHC , GuptaV , SihotaR . Evaluation of contact versus non‐contact diode laser cyclophotocoagulation for refractory glaucomas using similar energy settings. Clinical and Experimental Ophthalmology2004;32:33‐8. ">Agarwal 2004</a>; <a href="./references#CD012223-bbs2-0015" title="EgbertPR , FiadoyorS , BudenzD , ShieldsMB . Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open‐angle glaucoma. Evidence‐Based Eye Care2001;2(4):238‐9. EgbertPR , FiadoyorS , BudenzDL , DadzieP , ByrdS . Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open‐angle glaucoma. Archives of Ophthalmology2001;119(3):345‐50. ">Egbert 2001</a>; <a href="./references#CD012223-bbs2-0021" title="LiuG , TangGL . Effect of transscleral diode laser cyclophotocoagulation and cyclocryosurgery in treatment of severe glaucoma. International Journal of Ophthalmology2008;8(8):1673‐4. ">Liu 2008</a>; <a href="./references#CD012223-bbs2-0028" title="TzamalisA , PhamDT , WirbelauerC . Diode laser cyclophotocoagulation versus cyclocryotherapy in the treatment of refractory glaucoma. European Journal of Ophthalmology2011;21(5):589‐96. ">Tzamalis 2011</a>). We excluded five additional studies because they had been reported in abstracts (Brooks 1993a; Korte 2002a; Marcus 1992a; Miller‐Meeks 1994a; Zweifach 1997a). </p> </section> </section> <section id="CD012223-sec-0076"> <h3 class="title">Risk of bias in included studies</h3> <p>We judged one included study to have low risk of bias for most domains (<a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>). We classified the other four studies as having unclear risk of bias for the majority of the domains, with high risk for some domains in <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> and <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> . See <a href="#CD012223-fig-0002">Figure 2</a> for details. </p> <div class="figure" id="CD012223-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012223-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012223-sec-0077"> <h4 class="title">Allocation</h4> <p>We judged selection bias in two parts: random sequence generation and allocation concealment before assignment. </p> <p>We judged all included studies to have unclear risk of selection bias based on random sequence generation, largely due to lack of information. <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> did not specify that computer randomization was used, but stated that randomization codes were obtained from opaque, sealed envelopes. <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> and <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> did not report sequence generation. <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> reported that participants were randomized using a series of random numbers, but did not clarify how the numbers were generated. The authors of <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> stated that their participants were not truly randomized, as they randomized only the first participant and thereafter alternated between the two interventions. We judged this study to be at high risk for selection bias, although the authors stated that they believed their method was a way to assign the same number of eyes to each group; that there were no biases in the eligibility criteria; and their method "did not influence the distribution" of the participants. </p> <p>We judged only one study to have low risk of bias based on allocation concealment: <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> reported the use of opaque, sealed envelopes. Allocation concealment before assignment was not mentioned in the reports of the rest of the included studies. </p> <section id="CD012223-sec-0078"> <h5 class="title">Masking (performance bias and detection bias)</h5> <p>We judged <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> to have low risk of both performance and detection bias, as it was stated that participants and outcome assessors were masked. The report authors noted that it was not possible to mask the surgeon due to the need to use different probes in the two interventions. </p> <p>In <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>, masking of participants or study personnel was not possible due to the nature of the interventions (cyclodestructive procedure or drainage device implantation), therefore we judged this study to be at high risk of performance bias. Similarly, in <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>, the CPC procedures were performed by unmasked surgeons, resulting in a judgement of high risk of performance bias. Neither of these studies reported whether outcomes assessors were masked, thus we judged both to have an unclear risk of detection bias. </p> <p>Two studies did not mention masking; we judged them to have unclear risk of both performance and detection bias (<a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>; <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a>). </p> </section> </section> <section id="CD012223-sec-0079"> <h4 class="title">Incomplete outcome data</h4> <p>We judged one of the included studies to have low risk of attrition bias: <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> reported no participants lost to follow‐up at the one‐year visit. In two studies, participants who were excluded or lost to follow‐up were simply excluded from the final analysis (45% and 14.7% for <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> and <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>, respectively, three months after intervention). We rated both studies as having a high risk of attrition bias. We judged <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> to have unclear risk of attrition bias because the number of participants who were excluded and/or lost to follow‐up, if any, was not reported. We judged <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> to have an unclear risk of attrition bias because the length of follow‐up varied among participants after the four‐week mark. </p> </section> <section id="CD012223-sec-0080"> <h4 class="title">Selective reporting</h4> <p>Four included studies had no protocol available, thus it was unclear whether there was selective reporting bias (<a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>; <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>; <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>; <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a>). We judged only included study to have low risk of selective reporting, as all outcomes for which data had been collected were reported (<a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>). </p> </section> <section id="CD012223-sec-0081"> <h4 class="title">Other potential sources of bias</h4> <p>We rated one study as at low risk of other potential sources of bias (<a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>). We judged <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>, <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>, <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>, and <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> to have unclear risk of bias for this domain because financial sources and conflicts of interest were not reported. </p> </section> </section> <section id="CD012223-sec-0082"> <h3 class="title" id="CD012223-sec-0082">Effects of interventions</h3> <p>See: <a href="./full#CD012223-tbl-0001"><b>Summary of findings for the main comparison</b> Endoscopic cyclophotocoagulation compared with the Ahmed drainage implant for refractory glaucoma</a>; <a href="./full#CD012223-tbl-0002"><b>Summary of findings 2</b> Micropulse versus continuous‐wave cyclophotocoagulation for refractory glaucoma</a>; <a href="./full#CD012223-tbl-0003"><b>Summary of findings 3</b> Comparison of two cyclophotocoagulation lasers for refractory glaucoma</a>; <a href="./full#CD012223-tbl-0004"><b>Summary of findings 4</b> Comparison of two cyclophotocoagulation energy levels for refractory glaucoma</a> </p> <section id="CD012223-sec-0083"> <h4 class="title">Primary comparison: cyclodestructive procedure versus another glaucoma treatment</h4> <p>Only one of the included studies compared a cyclodestructive procedure with another type of glaucoma treatment (<a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>). The Ahmed tube shunt was implanted in a standard fashion and tube secured 8 mm from the limbus in the superior temporal quadrant and positioned 2 to 3 mm into the anterior chamber. The ECP was performed by a superior temporal pars plana incision, 3.5 mm from the limbus with a power of 0.5 W, continuous mode for approximately 2 seconds to 210 degrees of the ciliary body. </p> <section id="CD012223-sec-0084"> <h5 class="title">Primary outcome: change from baseline in pain control</h5> <p>Change in pain severity was not assessed.</p> </section> <section id="CD012223-sec-0085"> <h5 class="title">Secondary outcome: mean change in intraocular pressure from baseline</h5> <p><a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> reported mean IOP at various time points rather than the mean change in IOP from baseline. Because baseline IOP was similar in both groups (41.61 mmHg in the ECP group and 41.32 mmHg in the Ahmed implant group), we used the mean difference (MD) in mean IOPs to estimate the between‐group treatment effects (<a href="./references#CD012223-fig-0003" title="">Analysis 1.1</a>). At one‐week follow‐up, the group that received ECP had higher IOP compared with the group that received the Ahmed implant (MD 4.12 mmHg, 95% confidence interval (CI) 1.79 to 6.45). At one month postoperatively, the mean IOPs in the two groups were similar (MD 0.56 mmHg, 95% CI ‐2.50 to 3.62). At three months, the group that received ECP had lower IOP compared with the group that received the Ahmed implant (MD ‐6.83 mmHg, 95% CI ‐9.73 to ‐3.93). At six months, the group that received ECP still had lower IOP compared with the group that received the Ahmed implant, although there was less of difference than at three months (MD ‐3.78 mmHg, 95% CI ‐6.18 to ‐1.38). At 12 and 24 months, the mean IOPs were again similar in both groups (MD ‐1.14 mmHg, 95% CI ‐4.21 to 1.93 and MD ‐0.66 mmHg, 95% CI ‐4.30 to 2.98, respectively). It was noted that reduced IOP from baseline stabilized after two months in eyes treated with ECP, but gradually rose, then reduced, in the Ahmed implant group. We assessed the certainty of evidence for IOP outcomes as low, downgrading for risk of bias (‐1) and imprecision (‐1). </p> </section> <section id="CD012223-sec-0086"> <h5 class="title">Secondary outcome: mean change in best‐corrected visual acuity in study eyes at 12 months postintervention </h5> <p>Mean change in visual acuity at 12 months postintervention was not reported; however, mean logMAR visual acuity at 24 months postintervention was reported. At 24 months postintervention, visual acuity in logMAR was 0.74 ± 0.42 for 28 participants in the ECP group and 0.98 ± 0.61 for 26 participants in the Ahmed implant group (MD ‐0.24 logMAR, 95% CI ‐0.52 to 0.04). In addition, at 24 months postoperatively, fewer participants in the ECP group (16%) were classified as having worse visual acuity from baseline than in the Ahmed implant group (37.5%). The authors did not define how much worse than baseline they used for classifying "visual acuity worsening," nor did the authors report the numerator or denominators for these proportions. We assessed the certainty of evidence for visual acuity outcomes as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0087"> <h5 class="title">Secondary outcome: mean change in the mean deviation in study eyes from baseline at 12 months postintervention </h5> <p>This outcome was not assessed in <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>. </p> </section> <section id="CD012223-sec-0088"> <h5 class="title">Secondary outcome: mean number of glaucoma medications at 12 months postintervention</h5> <p>Mean number of glaucoma medications was reported at 24 months rather than at 12 months. The mean number of glaucoma medications was 2.0 ± 1.2 in the ECP group (n = 28) and 2.5 ± 1.3 in the Ahmed drainage implant group (n = 26) (MD ‐0.50, 95% CI ‐1.17 to 0.17). We assessed the certainty of evidence for number of glaucoma medications as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0089"> <h5 class="title">Secondary outcome: proportion of study eyes requiring additional glaucoma surgery by 12 months postintervention </h5> <p><a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> did not report whether any eye required additional glaucoma surgery by 12 months postintervention. </p> </section> <section id="CD012223-sec-0090"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a> reported "complications during the study" rather than a specific follow‐up time. Prolonged inflammation was not reported; one case of hypotony and one case of phthisis bulbi were identified in the ECP group (2.9% of 34 participants), but none in the Ahmed implant group. Conversely, one case of endophthalmitis was reported in the group that received the Ahmed drainage implant, compared with none in the ECP group (2.9% of 34 participants). Retinal detachment occurred in both study arms, in one participant in the ECP group (2.9%) and two participants in the Ahmed implant group (5.9%). No case of choroidal hemorrhage was reported; however, choroidal detachment occurred in one participant in the ECP group (2.9%) compared with six participants in the Ahmed implant group (17.6%). We assessed the certainty of evidence for adverse events as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0091"> <h5 class="title">Quality of life</h5> <p>This outcome was not assessed or reported by <a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>. </p> </section> </section> <section id="CD012223-sec-0092"> <h4 class="title">Secondary comparison: cyclodestructive procedure versus another cyclodestructive procedure</h4> <section id="CD012223-sec-0093"> <h5 class="title">Micropulse cyclophotocoagulation versus continuous‐wave cyclophotocoagulation</h5> <p>In micropulse CPC, the laser is used with repetitive, short pulses of energy (2 W) separated by a break period for a total of 62.5 J. This was compared with the conventional CPC method (1.4 to 2 W, 2 seconds per burn, 20 to 28 burns/eye; 60 to 112 J), which uses a continuous wave of high energy delivered to the eye, in <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>. </p> <section id="CD012223-sec-0094"> <h6 class="title">Primary outcome: change from baseline in pain control</h6> <p>Pain control at 12 months was not assessed in <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>. However, before treatment and one week after treatment, the study investigators asked participants to rate their pain levels as "no pain," "mild," "moderate," or "severe." Before surgery the numbers of participants who rated their pain as "mild" and "moderate" were six (27%) and one (5%), and seven (32%) and one (4%), in the micropulse CPC group (n = 22) and the continuous‐wave CPC group (n = 22), respectively. No participant said they had "severe" pain before surgery. After surgery, all participants in the micropulse CPC group reported "no pain," while two (9%) and one (5%) in the continuous‐wave CPC group rated pain as "mild" and "moderate," respectively. No participant in either group said they had "severe" pain at one week after surgery. It should be noted that the study authors interpreted pain ratings from the first week assessment as equivalent to discomfort related to the laser treatment and not to glaucoma. </p> </section> <section id="CD012223-sec-0095"> <h6 class="title">Secondary outcome: mean change in intraocular pressure from baseline</h6> <p><a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> did not present mean IOPs, but reported that the median IOP was not significantly different between the two groups at any time point. This study used survival analysis to show a significant difference in the number of participants who had achieved an IOP between 6 mmHg and 21 mmHg with at least 30% IOP reduction from baseline (the study's primary outcome) at one year: 75% of participants in the micropulse CPC group (n = 24) compared with 29% of participants in the continuous‐wave CPC group (n = 24). By 18 months postoperatively, they reported no statistically significant difference. </p> </section> <section id="CD012223-sec-0096"> <h6 class="title">Secondary outcome: mean change in best‐corrected visual acuity in study eyes at 12 months postintervention </h6> <p>Mean change in visual acuity was not reported in <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>, but the report stated that one participant in the micropulse CPC group (n = 23) and two participants in the continuous‐wave CPC group (n = 23) exhibited worsened visual acuity. </p> </section> <section id="CD012223-sec-0097"> <h6 class="title">Secondary outcome: mean change in the mean deviation in study eyes from baseline to 12 months postintervention </h6> <p>This outcome was not reported in <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>. </p> </section> <section id="CD012223-sec-0098"> <h6 class="title">Secondary outcome: mean number of glaucoma medications at 12 months postintervention</h6> <p><a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> did not assess the number of glaucoma medications used by participants at 12 months postintervention. The study authors reported that at the 18‐month follow‐up, the median number of IOP‐lowering medications was reduced from two to one in both the micropulse CPC group and the continuous‐wave CPC group. </p> </section> <section id="CD012223-sec-0099"> <h6 class="title">Secondary outcome: proportion of study eyes requiring additional glaucoma surgery by 12 months postintervention </h6> <p>This outcome was not reported in <a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>. </p> </section> <section id="CD012223-sec-0100"> <h6 class="title">Adverse events</h6> <p>The authors noted that they observed more complications in the continuous‐wave CPC group than in the micropulse CPC group. Prolonged anterior chamber inflammation and phthisis bulbi occurred in more eyes treated with continuous‐wave CPC compared with micropulse CPC (seven eyes or 30% versus one eye or 4% for prolonged inflammation and one eye or 4% versus no eyes for phthisis bulbi, for continuous‐wave CPC and micropulse CPC, respectively). Hypotony was observed in five eyes treated with continuous‐wave CPC but none treated with micropulse CPC. Other adverse events such as fibrin exudates, endophthalmitis, retinal detachment, and choroidal hemorrhage were not mentioned. </p> </section> <section id="CD012223-sec-0101"> <h6 class="title">Quality of life</h6> <p><a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a> did not assess quality of life. </p> </section> </section> <section id="CD012223-sec-0102"> <h5 class="title">Cyclophotocoagulation using a semiconductor diode laser versus Nd:YAG laser</h5> <p>Two trials compared two types of cyclodestructive lasers (<a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a>; <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a>). In both trials, a 810‐nanometer diode laser was compared to a 1064‐nanometer Nd:YAG laser; however, the two trials used different brands of diode lasers (<a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> used the Microlase continuous‐wave semiconductor diode laser, and <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> used the OcuLight SLx with a handheld fiber optic G‐probe diode laser). </p> <section id="CD012223-sec-0103"> <h6 class="title">Primary outcome: change from baseline in pain control</h6> <p>Neither trial reported outcomes related to pain control.</p> </section> <section id="CD012223-sec-0104"> <h6 class="title">Secondary outcome: mean change in intraocular pressure from baseline</h6> <p>Both trials reported mean IOP at one week and one month after surgery. There was uncertainty as to which intervention group had a lower IOP when comparing the semiconductor laser with the Nd:YAG laser at these time points (MD ‐1.45 mmHg, 95% CI ‐5.70 to 2.80 and MD ‐0.69 mmHg, 95% CI ‐4.29 to 2.90, for one week and one month, respectively) (<a href="./references#CD012223-fig-0004" title="">Analysis 2.1</a>). At three months, <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> reported an MD of ‐1.90 mmHg (95% CI ‐15.84 to 12.04) when comparing the group that received cyclodestructive surgery with a semiconductor diode laser versus with an Nd:YAG laser. However, many participants were not included in the three‐month follow‐up (40% in the semiconductor diode group and 50% in the Nd:YAG group). <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported the mean IOP at 6 months and 12 months postoperatively: MD ‐0.06 mmHg (95% CI ‐3.28 to 3.16) and MD 1.02 mmHg (95% CI ‐1.49 to 3.53), respectively. It should be noted that <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> did not provide the total number of participants analyzed for each time point; in our analysis, we used the number randomized into each intervention. The study did not provide details about missing data or loss to follow‐up. We assessed the certainty of evidence for IOP outcomes as low, downgrading for risk of bias (‐1) and imprecision (‐1). </p> </section> <section id="CD012223-sec-0105"> <h6 class="title">Secondary outcome: mean change in best‐corrected visual acuity in study eyes at 12 months postintervention </h6> <p>Neither trial reported mean change in best‐corrected visual acuity; however, both trials reported some information related to visual acuity. <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> reported that the evaluation of visual acuity measurements was "inconclusive owing to the very poor visual function in the majority of treated eyes at entry level." It was stated that there was no significant change in vision and no significant difference in the course of visual acuity based on the laser used, but quantitative data were not provided. <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported that at the last follow‐up visit, 25 of 34 participants in the diode group and 25 of 30 participants in the Nd:YAG group showed increased corrected visual acuity of more than two lines on the Snellen chart (or one line on the low‐vision category) or no change in corrected visual acuity (risk ratio (RR) 0.88, 95% CI 0.68 to 1.14). Thus, they also reported that visual acuity was decreased in nine participants in the diode group and five participants in the Nd:YAG group (RR 1.59, 95% CI 0.60 to 4.22). We assessed the certainty of evidence for visual acuity outcomes as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0106"> <h6 class="title">Secondary outcome: mean change in the mean deviation in study eyes from baseline at 12 months postintervention </h6> <p>Neither <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> nor <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported visual field outcomes. </p> </section> <section id="CD012223-sec-0107"> <h6 class="title">Secondary outcome: mean number of glaucoma medications at 12 months postintervention</h6> <p>Neither <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> nor <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported on the number of glaucoma medications used by participants after the CPC procedure. </p> </section> <section id="CD012223-sec-0108"> <h6 class="title">Secondary outcome: proportion of study eyes requiring additional glaucoma surgery by 12 months postintervention </h6> <p><a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> did not report on the number of participants who needed additional glaucoma surgery. <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported that 6/49 (12.2%) participants in the diode laser group and 4/46 (8.6%) in the Nd:YAG laser group underwent repeat CPC (RR 1.41, 95% CI 0.42 to 4.67). They did not note the assessment time point or whether other participants underwent other additional glaucoma surgeries. We assessed the certainty of evidence for this outcome as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0109"> <h6 class="title">Adverse events</h6> <p>We were unable to synthesize adverse event outcome data, as they were reported at different time points: three months in <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> and 12 months in <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a>. </p> <p><a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> reported that one of 20 (5%) participants in the diode laser group had very mild anterior segment inflammatory response and conjunctival burns. Five of 20 (25%) participants in the Nd:YAG group experienced adverse events on the first day after surgery: hypotony occurred in three participants and hyphema and subconjunctival hemorrhage occurred in one participant each. The authors reported that all complications resolved within two weeks. No other adverse events were reported. </p> <p><a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> reported that two of 49 (4%) participants in the diode laser group had hypotony; three (6%) had hyphema; and one participant had phthisis. One of 46 participants (2%) in the Nd:YAG laser group had hypotony, and one participant had hyphema. It was also noted that mild anterior segment inflammation was seen in all participants, especially following the CPC procedures. </p> </section> <section id="CD012223-sec-0110"> <h6 class="title">Quality of life</h6> <p>Neither <a href="./references#CD012223-bbs2-0004" title="UlbigM , McHughDA , HamiltonPA . A clinical comparison of semiconductor diode versus Nd:YAG cycloablation. American Academy of Ophthalmology1992:Abstract 135. UlbigMW , McHughDA , McNaughtAI , HamiltonPA . Clinical comparison of semiconductor diode versus neodymium: YAG non‐contact cyclo photocoagulation. British Journal of Ophthalmology1995;79(6):569‐74. ">Ulbig 1995</a> nor <a href="./references#CD012223-bbs2-0005" title="YounJ , CoxTA , HerndonLW , AllinghamRR , ShieldsMB . A clinical comparison of transscleral cyclophotocoagulation with neodymium: YAG and semiconductor diode lasers. American Journal of Ophthalmology1998;126(5):640‐7. ">Youn 1998</a> assessed quality of life. </p> </section> </section> <section id="CD012223-sec-0111"> <h5 class="title">Cyclophotocoagulation using an Nd:YAG laser at 8 J versus 4 J</h5> <p>One study compared CPC using two different energy settings (<a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>). Outcomes were reported at one day postintervention and at final follow‐up (mean of 12.6 months in the 8‐joule group and 12.7 in the 4‐joule group). </p> <section id="CD012223-sec-0112"> <h6 class="title">Primary outcome: change from baseline in pain control</h6> <p><a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> did not assess the change from baseline in pain control at 12 months follow‐up; however, data on pain, self reported as "none," "moderate," or "severe" on the day after surgery, were reported in a subset of participants. Fewer participants in the 8‐joule group (8/26) reported no pain on the day after surgery than in the 4‐joule group (12/24) (RR 0.62, 95% CI 0.31 to 1.24). Thus, more participants in the 8‐joule group (18/26) than in the 4‐joule group (12/24) reported moderate or severe pain (RR 1.38, 95% CI 0.86 to 2.23). We assessed the certainty of evidence for pain outcomes as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0113"> <h6 class="title">Secondary outcome: mean change in intraocular pressure from baseline</h6> <p>Change in IOP was measured only at the two‐hour and one‐day postoperative examinations. Among participants who had the same or lower IOP at one day postoperatively compared with baseline (96% in the 8‐joule group and 88% in the 4‐joule group), the mean reductions in IOP were 15.5 mmHg and 14.5 mmHg for the 8‐joule and 4‐joule groups, respectively. The variation in means (e.g. standard deviation) was not reported, thus we did not calculate the between‐group mean difference. One participant in the 8‐joule group and three participants in the 4‐joule group had a rise in pressure (increase of 1 mmHg in the 8‐joule group and 6 to 23 mmHg in the 4‐joule group). </p> </section> <section id="CD012223-sec-0114"> <h6 class="title">Secondary outcome: mean change in best‐corrected visual acuity in study eyes at 12 months postintervention </h6> <p>In <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>, visual acuity changes were reported for the participants who did not require further surgery up to final follow‐up: 33 (75%) of the 8‐joule group and 27 (60%) of the 4‐joule group. Visual acuity was unchanged or improved in 21/33 participants in the 8‐joule group and 20/27 participants in the 4‐joule group (RR 0.86, 95% CI 0.61 to 1.21). Thus, visual acuity was reduced in 12/33 participants in the 8‐joule group and 7/27 participants in the 4‐joule group (RR 1.40, 95% CI 0.64 to 3.06). We assessed the certainty of evidence for visual acuity outcomes as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0115"> <h6 class="title">Secondary outcome: mean change in the mean deviation in study eyes from baseline at 12 months postintervention </h6> <p>This outcome was not reported by <a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a>. </p> </section> <section id="CD012223-sec-0116"> <h6 class="title">Secondary outcome: mean number of glaucoma medications at 12 months postintervention</h6> <p><a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> did not report the mean number of glaucoma medications at 12 months postintervention, but stated that 17/31 (54.8%) participants in the 8‐joule group and 7/19 (36.8%) participants in the 4‐joule group reduced the number of medications they were taking, though the time point of this assessment was not reported (RR 1.49, 95% CI 0.76 to 2.91). Again, only participants who did not require further surgery were assessed for this outcome. We assessed the certainty of evidence for this outcome as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0117"> <h6 class="title">Secondary outcome: proportion of study eyes requiring additional glaucoma surgery by 12 months postintervention </h6> <p><a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> reported that 33/44 (75%) and 27/45 (60%) participants treated with the 8‐joule and 4‐joule Nd:YAG laser, respectively, required no additional glaucoma surgery by the last follow‐up time point in the study. Eleven of 44 (25%) participants in the 8‐joule group compared with 18/45 participants (40%) in the 4‐joule group required additional glaucoma surgery after the first CPC procedure (RR 0.63, 95% CI 0.33 to 1.17). We assessed the certainty of evidence for additional surgeries as very low, downgrading for risk of bias (‐1), imprecision (‐1), and indirectness (‐1). </p> </section> <section id="CD012223-sec-0118"> <h6 class="title">Adverse events</h6> <p>Severe reactions, defined as the presence of fibrin or hyphema, were seen in five participants who received 8 J of energy and were not observed in the group treated with 4 J of energy two hours after the intervention. One day after surgery, there were mild, medium, and severe anterior chamber reactions in one (3%), 14 (54%), and 11 (42%) of the 26 participants who received 8 J of energy during their Nd:YAG CPC, respectively. There was a mild anterior chamber reaction in four participants (19%), a moderate anterior chamber reaction in 15 participants (71%), and a severe reaction in two participants (10%) of 21 participants who received 4 J of energy. </p> </section> <section id="CD012223-sec-0119"> <h6 class="title">Quality of life</h6> <p><a href="./references#CD012223-bbs2-0003" title="ShieldsMB , WilkersonMH , EchelmanDA . A comparison of two energy levels for noncontact transscleral neodymium‐YAG cyclophotocoagulation. Archives of Ophthalmology1993;111(4):484‐7. ">Shields 1993</a> did not assess quality of life. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012223-sec-0120" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012223-sec-0120"></div> <section id="CD012223-sec-0121"> <h3 class="title" id="CD012223-sec-0121">Summary of main results</h3> <p>We identified five trials that met the inclusion criteria for this review. These studies analyzed outcomes for 330 eyes of 326 participants. The studies were conducted in Brazil, Singapore, the United Kingdom, and the United States. We judged one study to have a low risk of bias for most 'Risk of bias' domains; we judged the other studies to be at unclear risk of bias overall. This review included four different comparisons: </p> <p> <ol id="CD012223-list-0006"> <li> <p>ECP versus Ahmed implant (1 RCT, 68 eyes, <a href="./full#CD012223-tbl-0001">summary of findings Table for the main comparison</a>); </p> </li> <li> <p>micropulse CPC versus continuous‐wave CPC (1 RCT, 48 eyes, <a href="./full#CD012223-tbl-0002">summary of findings Table 2</a>); </p> </li> <li> <p>CPC with a diode laser versus Nd:YAG laser (2 RCTs, 135 eyes, <a href="./full#CD012223-tbl-0003">summary of findings Table 3</a>); and </p> </li> <li> <p>CPC with an Nd:YAG laser emitting 8 J versus 4 J of energy (1 RCT, 89 eyes, <a href="./full#CD012223-tbl-0004">summary of findings Table 4</a>). </p> </li> </ol> </p> <p>No study reported data for our primary outcome, change from baseline in pain control as reported by the participant or change in number of pain medications. In two studies, participants were asked to rate their level of pain after surgery, but these pain ratings were regarded as equivalent to discomfort related to the treatment rather than related to disease control. </p> <p>Our primary comparison was a cyclodestructive procedure versus another glaucoma treatment. The comparison identified for this review was ECP compared with an aqueous shunt implant. Pain was not assessed in this study. Intraocular pressure was higher in the group that received ECP at one week; similar at one month; higher in the group that received the Ahmed implant at three and six months; and similar at the 12‐ and 24‐month follow‐up. Visual acuity was not significantly different at 24 months postintervention, although it was noted that the aqueous shunt group had a greater incidence of eyes in which visual acuity had worsened. </p> <p>Three types of comparisons from four included studies fit our secondary comparison. The study that compared micropulse with continuous‐wave CPC did ask participants about pain, but indicated that any pain reported one week after surgery was due to the laser treatment and not glaucoma. This study reported median rather than mean IOPs, but stated that IOP was similar between the two groups at all time points. In addition, more complications were noted in the continuous‐wave CPC group. Two studies compared a semiconductor diode versus an Nd:YAG laser for CPC. Pain was not an outcome in either study, but we were able to perform a meta‐analysis on the IOPs at one week and one month postoperatively (MD ‐1.5, 95% CI ‐5.7 to 2.8 and MD ‐0.7, 95% CI ‐4.3 to 2.9, respectively). The last comparison was a study comparing CPC using the same type of laser but with different energy settings. There were no significant differences in outcomes based on level of energy for IOP, visual acuity, and number of glaucoma medications required, however more serious adverse events occurred in the participants who were treated with CPC at a higher energy setting. </p> <p>The most commonly reported adverse events across all five studies were hypotony and phthisis bulbi. There did not appear to be a statistically significant difference in the incidence of these events by type of surgery. Since adverse events were reported at various time points and sometimes only broadly as "during follow‐up," only minimal synthesis of the data was possible. </p> </section> <section id="CD012223-sec-0122"> <h3 class="title" id="CD012223-sec-0122">Overall completeness and applicability of evidence</h3> <p>This review included five studies with very different interventions. Though each study included at least one arm that was a cyclodestructive procedure, meta‐analysis of outcome data was limited to two studies. Our primary goal in this review was to compare cyclodestructive procedures with other glaucoma treatments. Unfortunately, only one study analyzed this type of comparison. That study compared ECP with an aqueous shunt. We did not identify any other studies that used ECP, so while we found a lack of conclusive evidence about the benefit of ECP versus an Ahmed implant, we were unable to compare ECP to other types of CPC or other cyclodestructive procedures. Among the studies that compared CPC with different parameters, many outcomes were not reported. While it may be useful to know whether outcomes are better with a certain type of laser (micropulse compared with continuous stream, for example), such studies do not provide insight into whether CPC in any form provides better outcomes for refractory glaucoma patients compared with other types of cyclodestructive surgery or traditional glaucoma surgeries. </p> <p>Two of our outcomes of interest were not reported in any of the included studies. In addition to pain, we were interested in the quality of life of participants undergoing the various treatments and cyclodestructive procedures. Information for this outcome would be useful, as patient‐reported outcomes can help support a surgery if efficacy and safety are similar between the two. Additionally, visual field data were not reported in any of the included studies. This outcome is clinically important as it evaluates vision loss due to glaucoma and can complement IOP measures for determining the severity of the disease. However, given that people with refractory glaucoma are at a very advanced stage of the disease with a very low acuity and advanced visual field defects, it may be difficult to properly assess the effect of treatment on quality of life or visual field loss. </p> <p>There is also some concern about the differences in the types of participants included in this review. Most of the studies enrolled participants in which traditional surgical approaches had failed or were not possible/not appropriate. One study specified that they would only enroll participants who had at least one previous trabeculectomy, while another allowed participants "with or without previous surgical intervention." These differences in types of participants help cover the spectrum of 'real‐world' glaucoma patients, but make it difficult to compare the results of one study to the results of another. </p> <section id="CD012223-sec-0123"> <h4 class="title">Certainty of the evidence</h4> <p>Due to the differences in interventions across our five included studies, we were able to conduct a meta‐analysis using data from only two studies. Several of our outcomes of interest were not reported in these two studies. Intraocular pressure at a time point was the only outcome for which we were able to conduct meta‐analysis. We graded the certainty of the evidence as low, downgrading for risk of bias because one of the trials had serious issues with potential attrition bias and imprecision of the effect estimates. For other outcomes in the review, we also downgraded for indirectness because outcomes were reported at shorter time points or at "final" follow‐up visits, which were not consistent among all participants in a trial. </p> </section> </section> <section id="CD012223-sec-0124"> <h3 class="title" id="CD012223-sec-0124">Potential biases in the review process</h3> <p>We followed Cochrane standards for this review with the hopes of minimizing bias. Two review authors independently screened the studies and made decisions on inclusion. Data were extracted independently by two review authors and then reconciled by a third review author. Potential bias could arise due to the fact that much of the trial reporting was unclear. At some points in this review we had to make decisions and assumptions about the number of participants in order to analyze the data in a meaningful way. Additonally, we chose to include one trial that was quasi‐randomized based on the study authors reporting that their quasi‐randomization process was as good as true randomization. </p> </section> <section id="CD012223-sec-0125"> <h3 class="title" id="CD012223-sec-0125">Agreements and disagreements with other studies or reviews</h3> <p>There are few large studies or other reviews examining cyclodestructive procedures. To our knowledge, there has been no systematic review that attempted to evaluate all types of cyclodestructive procedures that: (a) compared cyclodestructive procedures with other glaucoma surgeries and (b) compared cyclodestructive procedures with each other, as we have done in this review. We did identify a small number of publications to which we can compare our results. A retrospective cohort analysis of 5570 Medicare patients who underwent either cyclodestructive procedure or a drainage device procedure found that when repeat procedures were not included in the definition of an adverse outcome, eyes that received a drainage device procedure had 3.8 times higher odds of an adverse outcome than eyes that received a cyclodestructive procedure (odds ratio 3.8, 95% CI 3.07 to 4.67) (<a href="./references#CD012223-bbs2-0079" title="TopouzisF , YuF , ColemanAL . Factors associated with elevated rates of adverse outcomes after cyclodestructive procedures versus drainage device procedures. Ophthalmology1998;105(12):2276‐81. ">Topouzis 1998</a>). The cyclodestructive procedures in the study included cyclodialysis, cyclodiathermy, cyclocryotherapy, and cyclophotocoagulation. In the one study we included that compared a cyclodestructive procedure to a drainage device (<a href="./references#CD012223-bbs2-0002" title="LimaFE , MagachoL , CarvalhoDM , SusannaRJr , AvilaMP . A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed Drainage Implant in refractory glaucoma. Journal of Glaucoma2004;13(3):233‐7. LimaFE , MagachoL , GuimaraesN , AvilaM , SusannaR . A prospective, randomized, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Investigative Ophthalmology and Visual Science2003; Vol. 44:ARVO E‐Abstract 4294. ">Lima 2004</a>), there was an unclear difference in the risk of complications during the study. Another study published in 2001 reported that their aim was to evaluate the efficacy of contact diode laser CPC using different treatment parameters (<a href="./references#CD012223-bbs2-0068" title="MistlbergerA , LiebmannJ , TschidererH , RitchR , RuckhoferJ , GrabnerG . Diode laser transscleral cyclophotocoagulation for refractory glaucoma. Journal of Glaucoma2001;10(4):288‐93. ">Mistlberger 2001</a>). As part of our secondary comparison, we included one study that used contact diode for CPC (<a href="./references#CD012223-bbs2-0001" title="AquinoMC , BartonK , TanAM , SngC , LiX , LoonSC , et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation refractory glaucoma: a randomized exploratory study. Clinical and Experimental Ophthalmology2015;43(1):40‐6. ">Aquino 2015</a>). <a href="./references#CD012223-bbs2-0068" title="MistlbergerA , LiebmannJ , TschidererH , RitchR , RuckhoferJ , GrabnerG . Diode laser transscleral cyclophotocoagulation for refractory glaucoma. Journal of Glaucoma2001;10(4):288‐93. ">Mistlberger 2001</a> examined 206 eyes treated between April 1991 and September 1997 with a diode laser through a contact probe. Mean IOP was reduced from 42.1 ± 11.0 mmHg to 17.3 ± 10.9 mmHg at 12 months. This is an approximately 60% reduction in IOP from baseline. We did not identify large cohort studies and systematic reviews on the other types of interventions included in this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012223-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/urn:x-wiley:14651858:media:CD012223:CD012223-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_t/tCD012223-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012223-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012223-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/urn:x-wiley:14651858:media:CD012223:CD012223-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_t/tCD012223-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012223-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012223-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/urn:x-wiley:14651858:media:CD012223:CD012223-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_t/tCD012223-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Endoscopic cyclophotocoagulation versus aqueous shunt, Outcome 1 Mean intraocular pressure at a time point." data-id="CD012223-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Endoscopic cyclophotocoagulation versus aqueous shunt, Outcome 1 Mean intraocular pressure at a time point. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references#CD012223-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012223-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/urn:x-wiley:14651858:media:CD012223:CD012223-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_t/tCD012223-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cyclophotocoagulation using a semiconductor diode laser versus Nd:YAG laser, Outcome 1 Mean intraocular pressure at a time point." data-id="CD012223-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Cyclophotocoagulation using a semiconductor diode laser versus Nd:YAG laser, Outcome 1 Mean intraocular pressure at a time point. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references#CD012223-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/media/CDSR/CD012223/image_n/nCD012223-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012223-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endoscopic cyclophotocoagulation compared with the Ahmed drainage implant for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Endoscopic cyclophotocoagulation compared with the Ahmed drainage implant for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> endoscopic cyclophotocoagulation (ECP) </p> <p><b>Comparison:</b> Ahmed drainage implant </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>ECP</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Ahmed implant</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study reported IOP at 12 months postintervention rather than the mean change in IOP from baseline. At 12 months postintervention, the MD was ‐1.14 mmHg (95% CI ‐4.21 to 1.93) when comparing ECP with the Ahmed implant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean change in visual acuity at 12 months postintervention was not reported. At 24 months postintervention, visual acuity was better among participants in the ECP group than in the Ahmed implant group (MD ‐0.24 logMAR, 95% CI ‐0.52 to 0.04). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in mean deviation in study eyes</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean number of glaucoma medications used by participants in each group was reported at 24 months rather than at 12 months (MD ‐0.50, 95% CI ‐1.17 to 0.17). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events were reported up to 24 months postintervention. In the ECP group (34 participants), there was 1 case each of hypotony, phthisis bulbi, retinal detachment, and choroidal detachment. In the Ahmed implant group (34 participants), there was 1 case of endophthalmitis, 2 cases of retinal detachment, and 6 cases of choroidal detachment. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to high risks of bias (selection bias, performance bias, and attrition bias).<br/> <sup>2</sup>Downgraded due to imprecision (wide confidence intervals).<br/> <sup>3</sup>Downgraded due to indirectness (outcome assessed at a different time point). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Endoscopic cyclophotocoagulation compared with the Ahmed drainage implant for refractory glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012223-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Micropulse versus continuous‐wave cyclophotocoagulation for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Micropulse versus continuous‐wave cyclophotocoagulation for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> micropulse cyclophotocoagulation (CPC) </p> <p><b>Comparison:</b> continuous‐wave CPC </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Micropulse CPC</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Continuous‐wave CPC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain control at 12 months was not assessed. The study investigators asked participants to rate their pain levels as "no pain," "mild," "moderate," or "severe" before and 1 week after surgery; however, these assessments were attributed to pain related to the surgery itself rather than pain due to glaucoma. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study reported median IOP at a time point rather than mean change in IOP from baseline. Median IOP was reported to be similar between the 2 groups at all time points. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 participant in the micropulse CPC group and 2 participants in the continuous‐wave CPC group exhibited worsened visual acuity. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in the mean deviation in study eyes</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 18 months postintervention, the median number of IOP‐lowering medications was reduced from 2 to 1 in both groups. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fewer complications were observed in the micropulse CPC group than in the continuous‐wave CPC group up to 18 months postintervention. In the micropulse CPC group (23 participants), there was 1 case of prolonged inflammation. In the continuous‐wave CPC group (23 participants), there were 7 cases of prolonged inflammation, 5 cases of hypotony, and 1 case of phthisis bulbi. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>RCT:</b> randomized controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Micropulse versus continuous‐wave cyclophotocoagulation for refractory glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012223-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Comparison of two cyclophotocoagulation lasers for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Cyclophotocoagulation using a semiconductor diode laser compared with cyclophotocoagulation using an Nd:YAG laser for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> semiconductor diode laser </p> <p><b>Comparison:</b> Nd:YAG laser </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Nd:YAG laser</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Semiconductor diode laser</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported mean IOP at 12 months postintervention rather than the mean change in IOP from baseline. At 12 months postintervention, the MD was 1.02 mmHg (95% CI ‐1.49 to 3.53) when comparing the semiconductor diode laser with the Nd:YAG laser. The second study did not report mean IOP beyond 3 months of follow‐up. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>127<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported that evaluations of visual acuity measurements were inconclusive due to the poor visual function of eyes at entry, and the other study reported that at the last follow‐up visit, 25 of 34 participants in the semiconductor diode group and 25 of 30 participants in the Nd:YAG group showed increased corrected visual acuity of more than 2 lines on the Snellen chart (or 1 line on the low‐vision category) or no change in corrected visual acuity (RR 0.88, 95% CI 0.68 to 1.14). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in the mean deviation in study eyes</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported adverse events at 12 months follow‐up, and the other reported only adverse events that occurred the day following surgery, so data could not be combined. Hypotony was reported in both studies and occurred in 3 participants in each study. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>Nd:YAG:</b> neodymium:yttrium‐aluminum‐garnet; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to unclear or high risks of bias (selection bias, performance bias, and attrition bias).<br/> <sup>2</sup>Downgraded due to imprecision (wide confidence intervals).<br/> <sup>3</sup>Downgraded due to indirectness (outcome assessed at a different time point). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Comparison of two cyclophotocoagulation lasers for refractory glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012223-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Comparison of two cyclophotocoagulation energy levels for refractory glaucoma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Cyclophotocoagulation using an Nd:YAG at 4 J versus 8 J for refractory glaucoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with refractory glaucoma </p> <p><b>Intervention:</b> 4 J </p> <p><b>Comparison:</b> 8 J </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 J</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 J</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain control</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study reported levels of pain 1 day postintervention in a subset of participants: 8/26 participants in the 8‐joule group reported no pain on the day after surgery compared with 12/24 participants in the 4‐joule group (RR 0.62, 95% CI 0.31 to 1.24). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in IOP</b> </p> <p>measured in mmHg 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in IOP was only measured at the 2‐hour and 1‐day postintervention examinations.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in best‐corrected visual acuity</b> </p> <p>measured by logMAR 12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual acuity was unchanged or improved in 21/33 participants in the 8‐joule group and 20/27 participants in the 4‐joule group (RR 0.86, 95% CI 0.61 to 1.21). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in the mean deviation in study eyes</b> </p> <p>change from baseline</p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of glaucoma medications</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17/31 (54.8%) participants in the 8‐joule group and 7/19 (36.8%) participants in the 4‐joule group reduced the number of medications they were taking, though the time point of this assessment was not reported (RR 1.49, 95% CI 0.76 to 2.91). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Severe reactions, defined as the presence of fibrin or hyphema, were seen in 5 participants who received 8 J of energy and none who received 4 J of energy 2 hours after the intervention. 1 day after surgery, there was a severe anterior chamber reaction in 11/26 (42%) participants who received 8 J of energy and 2/21 (10%) participants who received 4 J of energy. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean change in quality of life scores</b> </p> <p>12 months postintervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>This outcome was not reported in the included studies.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>Nd:YAG:</b> neodymium:yttrium‐aluminum‐garnet; <b>RCT:</b> randomized controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to unclear or high risks of bias (selection bias, performance bias, and attrition bias).<br/> <sup>2</sup>Downgraded due to imprecision (wide confidence intervals).<br/> <sup>3</sup>Downgraded due to indirectness (outcome assessed at a different time point). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Comparison of two cyclophotocoagulation energy levels for refractory glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/full#CD012223-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012223-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endoscopic cyclophotocoagulation versus aqueous shunt</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean intraocular pressure at a time point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 One week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 One month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 One year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Two years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Endoscopic cyclophotocoagulation versus aqueous shunt</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references#CD012223-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012223-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cyclophotocoagulation using a semiconductor diode laser versus Nd:YAG laser</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean intraocular pressure at a time point <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 One week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.45 [‐5.70, 2.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 One month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐4.29, 2.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐15.84, 12.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐3.28, 3.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 One year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [‐1.49, 3.53]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cyclophotocoagulation using a semiconductor diode laser versus Nd:YAG laser</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012223.pub2/references#CD012223-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012223.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012223-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012223-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012223-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012223-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012223-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012223-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012223\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012223\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012223\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012223\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012223\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Qh5938oe&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012223.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012223.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012223.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012223.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012223.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726656102"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012223.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726656106"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012223.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e98f5da1e9368',t:'MTc0MDcyNjY1Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 